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Irrespective of the immune status, the vast majority of all lymphocytes reside in peripheral
tissues whereas those present in blood only amount to a small fraction of the total. It
has been estimated that T cells in healthy human skin outnumber those present in blood
by at least a factor of two. How lymphocytes within these two compartments relate to
each other is not well understood. However, mounting evidence suggest that the study
of T cell subsets present in peripheral blood does not reﬂect the function of their coun-
terparts at peripheral sites. This is especially true under steady-state conditions whereby
long-lived memory T cells in healthy tissues, notably those in epithelial tissues at body
surfaces, are thought to fulﬁll a critical immune surveillance function by contributing to
the ﬁrst line of defense against a series of local threats, including microbes, tumors, and
toxins, and by participating in wound healing.The relative scarcity of information regarding
peripheralT cells and the factors regulating their localization is primarily due to inherent dif-
ﬁculties in obtaining healthy tissue for the extraction and study of immune cells on a routine
basis. This is most certainly true for humans. Here, we review our current understanding
of T cell homing to human skin and compare it when possible with gut-selective homing.
We also discuss candidate chemokines that may account for the tissue selectivity in this
process and present a model whereby CCR8, and its ligand CCL1, selectively regulate the
homeostatic migration of memory lymphocytes to skin tissue.
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INTRODUCTION
Chemokines control leukocyte migration and fulﬁll essential
functions in homeostatic and inﬂammatory immune processes.
Homeostatic chemokines control leukocyte trafﬁc taking place
in the absence of inﬂammatory stimuli whereas inﬂammatory
chemokines are inducible and, therefore, control effector cell
recruitment to the site of infection and disease where inﬂamma-
tory chemokines are being produced.Chemokines and their recep-
tors do not work alone but instead require the concerted “trans”
action of cellular adhesion molecules that, ﬁguratively speaking,
provide the necessary “traction” for cell migration. The combi-
nation of chemokine receptors and adhesion molecules deﬁne
distinct address codes, based upon which leukocytes can either
remain in circulation or become engaged in secondary lymphoid
organs or gain access to peripheral tissues. The checkpoints for
leukocyte relocation are (i) the microvascular beds where selected
leukocytes exit the bloodstream via trans-endothelial migration,
(ii) the speciﬁc site(s) of chemokine production within the tissue
wheremigrating leukocytes interact with their target cells, and (iii)
the lymphatic vasculature controlling leukocyte exit from healthy
or inﬂamed tissues. Detailed knowledge about a cell’s address code
provides much information about its functional “quality.” Conse-
quently, the expression studies of distinct chemokine and adhesion
receptor combinations have been useful in functionally deﬁning
Abbreviations: 1,25(OH)2D3, 1,25-dihydroxycholecalciferol; APC, antigen-
presenting cells;DC,dendritic cells;DETC,dendritic epidermalT cell; iTreg, induced
Treg; LC, Langerhans cells; RA, retinoic acid; Treg, regulatory T cell.
the various leukocyte subsets, as best exempliﬁed by distinct classes
of T helper cells. In humans, most chemokine studies have been
performed with fresh or cultured leukocytes derived from periph-
eral blood. Here, we summarize our current knowledge about the
chemokine system in human skin and compare it (where allowed)
with the situation in mice. Human skin is constantly exposed to
a large variety of environmental hazards that include UV irradia-
tion, toxins, as well as commensal, and pathogenic microbes. The
species-speciﬁc environment and extended life spanmay explain in
part why human skin differs profoundly from standard laboratory
animals (rodents) in terms of tissue architecture and immune cell
composition. We will discuss the role of chemokines in regulating
tissue-selective homing of memory T cells with particular focus on
human skin, and propose amodel whereby the skin-selective hom-
ing of immune surveillance T cells in humans is regulated byCCL1
and its receptor CCR8. We also raise several unresolved issues that
are relevant for understanding tissue immune surveillance and
vaccination responses.
THE SKIN VERSUS GUT HOMING DICHOTOMY
Several excellent review articles discuss the substantial progress
achieved in mouse experiments targeting the role of chemokines
and adhesion molecules in the tissue-speciﬁc homing of leuko-
cytes (Agace, 2008; Mora et al., 2008; Sigmundsdottir and Butcher,
2008; Woodland and Kohlmeier, 2009; del Rio et al., 2010). This
research was based on earlier observations describing the corre-
lation between the sites of immune activation (vaccination) with
the instruction of tissue-homing properties in effector/memory
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T cells during immune response initiation in the draining lymph
nodes. In essence, the current paradigm is simple and calls for
the targeted release of tissue-derived factors during T cell priming
that instruct the tissue-speciﬁc leukocyte homing. For the gut, the
expressionCCR9 togetherwithα4β7 (orαEβ7) has been correlated
with the metabolism of vitamin A (retinol; Figure 1). The bulk of
dietary vitamin A is stored in the liver and is released in the form
of a complex with a protein chaperon (retinol-binding protein)
to ensure a steady-state level in blood circulation and peripheral
tissues (Niederreither and Dolle, 2008). The necessity of vitamin
A in organ development and eyesight is well established, but it is
becoming increasingly clear that vitamin A metabolites also affect
DC functions and, as brieﬂy discussed here, T cell mobilization.
In the gut, CD103+ DCs process vitamin A to retinoic acid (RA),
which acts on the nuclear receptors, composed of the retinoic acid
receptor (RAR),and the retinoicX receptor (RXR).Of note,RXR is
also shared with the vitamin D receptor (VDR; see below). Elegant
studies have now shown (i) that RA instills gut-homing receptors
(CCR9, α4β7) on murine T cells (Iwata et al., 2004), and (ii) that
gut-associated DCs express elevated levels of vitaminA-processing
enzymes leading to the localized release of RA that triggers CCR9
and α4β7 expression in T cells (Coombes et al., 2007; Jaensson
et al., 2008; Guilliams et al., 2010). The proximity of DCs and
T cells may ensure the undiluted transfer of DC-derived factors,
including RA, to responding T cells in the lymph nodes, although
the underlying mechanisms have not been studied. Mouse stud-
ies have revealed that RA production is a particular feature of
CD103+ DCs, which predominate in gut tissue whereas CD103−
DCs are less efﬁcient in doing so (Johansson-Lindbom et al., 2005;
Jaensson-Gyllenback et al., 2011). Intestinal CD103+ DCs and RA
are also involved in the induction of CCR9 and α4β7 in humans
T cells (Jaensson et al., 2008; Eksteen et al., 2009). Still, further
studies are needed to evaluate the relative contribution of gut DCs
versus tissue cells, such as intestinal epithelial cells that are also
capable of producing RA (Edele et al., 2008), or lymph node stro-
mal cells, which may be responsible for licensing DCs to process
RA (Hammerschmidt et al., 2008; Molenaar et al., 2009). Never-
theless, the selective metabolism of vitamin A by gut-associated
CD103+ DCs and its effect on expression of gut-homing recep-
tors on T cells ﬁts nicely with the above-mentioned tissue-homing
paradigm.
With respect to skin, recent evidence suggest the involvement
of another vitamin, vitamin D3, and especially its active metabo-
lite 1,25-dihydroxycholecalciferol (1,25(OH)2D3), as the environ-
mental cue for induction of the skin-selective homing receptor
CCR10 (Mora et al., 2008; Sigmundsdottir and Butcher, 2008;
FIGURE 1 |The involvement of vitamins in the programming
of tissue tropicT cells. Vitamins and vitamin precursors are provided by the
diet and, in the case of vitamin D3, sun exposure and stored as inactive
precursors in the liver or bile. Vitamins A and D precursors can be further
processed to their active metabolites, retinoic acid (RA), and
1,25-dihydroxycholecalciferol (1,25(OH)2D3), respectively, by tissue-resident
dendritic cells and, in some casesT cells, by processes involving intracellular
hydroxylases (P450) and dehydrogenases (ALDH, RALDH). These active
compounds bind to vitamin D (VDR–RXR) and retinoic acid (RAR–RXR)
receptors in the nucleus leading to induction of gene expression, which
affects both DC maturation andT helper cell differentiation. RA and
1,25(OH)2D3 signaling in DC have both been shown to promote IL-10
production and skewT cell differentiation towardTh2 andTreg development,
while signaling in T cells affects the expression of adhesion molecules and
chemokine receptors. Speciﬁcally, activation of RAR–RXR-dependent gene
expression leads to the expression of the gut-homing receptors CCR9 and
α4β7, while activation of VDR-RXR induces CCR10 expression but not the
expression of CLA, the skin-speciﬁc ligand for E/P-selectin. 1,25(OH)2D3,
1,25-dihydroxycholecalciferol (1,25(OH)2D3); RA, retinoic acid, P450,
cytochrome P450; ALDH, alcohol dehydrogenases; RALDH, retinal
dehydrogenases, VDR, vitamin D receptor; RAR, retinoic acid receptor; RXR,
retinoid X receptor.
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Figure 1). However, the expression of other skin homing recep-
tors, including human cutaneous T lymphocyte antigen (CLA),
mouse P/E-selectin ligands, and CCR4, are not affected or in some
cases even inhibited by vitamin D3 (Sokolov et al., 2009). In addi-
tion to dietary uptake, vitamin D3 is produced in skin in response
to solar UV-B irradiation from 7-dehydrocholesterol (Reichrath,
2007). In fact, there is no need for dietary vitamin D3 supple-
mentation, except in immunosuppressed patients (e.g., transplant
recipients) who need to avoid sun exposure and in the elderly.
Vitamin D3 is metabolized to its active form, 1,25(OH)2D3, by
hydrolases in the liver and kidney as well as in skin cells, includ-
ing keratinocytes and dendritic cells. Similar to RA, 1,25(OH)2D3
binds to heterodimeric nuclear receptors composed of the VDR
and RXR, which then trigger gene expression by interacting with
vitamin D response elements (VDREs). More importantly,VDREs
are present in the promoter region of human but not mouse
CCR10,whichmay explain the inability of 1,25(OH)2D3 to induce
CCR10 expression in mouse T cells (Sigmundsdottir et al., 2007).
Nocturnal or furry animals, which lack cutaneous vitamin D3
production, likely evolved a different mechanism for imprint-
ing skin homing properties in effector/memory T cells. This is
supported by the ﬁnding that skin-derived DCs from both mice
(lacking vitamin D3 metabolites) and humans are capable of
inducing a skin homing phenotype in responding T cells, indi-
cating that certain, as yet undeﬁned skin “factors” are likely to
instruct localDCs in both species (Mora et al., 2005). Furthermore,
the tissue-homing program of peripheral DCs can be overridden
when exposed to alternative tissue environments, demonstrat-
ing the plasticity of DCs to instruct tissue-homing properties in
T cells and, importantly, the presence of multiple and function-
ally overlapping tissue factors (Dudda et al., 2005; Rimoldi et al.,
2005; Edele et al., 2008; Hammerschmidt et al., 2008; Iliev et al.,
2009).
The vitamin A-vitamin D3 dichotomy in controlling homing
properties in T cells during peripheral immune responses provides
a plausible explanation for the observed trafﬁc of engaged T cells
to distinct peripheral sites. But many more questions remain.
VITAMINS
The ﬁnding that vitamin A induces CCR9 and integrin recep-
tor expression in T cells represents an important discovery (Iwata
et al., 2004). Yet, it is undisputed that the principal role of vita-
min A (and vitamin D3) is not the instruction of T cell migration
programs but rather the control of crucial and diverse metabolic
processes. Vitamin A metabolism also occurs in sites other than
the gut, including skin, where the treatment of disorders of ker-
atinization, such as Psoriasis, using topical, and/or oral retinoids
is well established (Roos et al., 1998). In addition, vitamin A con-
trols integrin α4 expression, which when combined with the β1
chain is frequently involved in T cell recruitment to inﬂammatory
sites (Kang et al., 2011), and vitamin D3 was shown to inhibit the
expression of the skin homing adhesion molecule CLA (Yamanaka
et al., 2008). Furthermore, vitamins A and D3 have a general effect
of DC function leading to Th2 and iTreg cell differentiation in
responding αβ T cells (Mora et al., 2008; Figure 1). Of interest,
VDR-deﬁcient mice do not show gross abnormalities in T cell
compartmentalization. Collectively, it is reasonable to assume that
the control of tissue-homing properties in T cells is more complex
than previously appreciated.
EFFECTOR VERSUS MEMORY T CELLS
Effector T cells, i.e., activated, short-lived T cells generated during
the onset of immune responses, not only travel to the tissue in
which the DCs have captured and processed the cognate antigens,
but disperse widely to other non-involved organs as well (Rein-
hardt et al., 2001; Liu et al., 2006; Brinkman et al., 2008). By doing
so, effector T cells may forestall dissemination of infectious agents
to other sites, but from the standpoint of homing, it means that
a particular tissue tropism induced during contact with tissue-
derived DCs does not override alternative trafﬁcking routes. This
indicates that in early immune responses redundancy, as opposed
to selectivity, is an essential element of protective immunity. As
such, we hypothesize that memory T cells (i.e., resting, long-lived
T cells that survive the T cell contraction phase) are the ones that
preferentially respond the tissue-selective localization cues.
HOMEOSTATIC VERSUS INFLAMMATORY T CELL TRAFFIC
During inﬂammation, the main goal of the infected tissue is
to recruit as many effector immune cells as possible. To do so,
the local release of inﬂammatory mediators in conjunction with
pathogen-derived products trigger an inﬂammatory cascade that
results in the release of inﬂammatory chemokines and the expres-
sionof inducible adhesionmolecules onmicrovascular endothelial
cells. Inﬂammatory chemokines generally act on a large array
of target cells and show a signiﬁcant amount of redundancy in
the recruitment of effector cells. As such, it is unclear to what
extent tissue-selective homingmechanisms support the inﬂamma-
tory chemokine-driven recruitment of effector cells. We postulate
that tissue-selective immune cell homing operates under steady-
state conditions and, thus, correlates with the tissue distribution
and/or retention of resting memory cells. In the following section
we discuss human skin as a site with speciﬁc needs for immune
protection and summarize the literature dealing with cutaneous
chemokines.
CHEMOKINES PRESENT IN HUMAN SKIN
In the gut, it is clear that the constitutive and selective expression
of CCL25 by intestinal epithelial cells recruits CCR9-expressing
lymphocytes to the small intestine, but the question still remains
as to whether a similar mechanism regulates the speciﬁc migration
of long-lived memory lymphocytes to skin tissue. Previous data
implicate CCR4,CCR6, and CCR10 in the recruitment of effectors
to mucosal sites in inﬂammation, but as we discuss below, these
receptors are unlikely to regulate homeostatic migration. In order
to identify potential candidates, one ﬁrst needs to identify those
chemokines that are expressed in skin and, much like CCL25 in
the gut, are largely absent at other locations.
Numerous chemokines have been detected by various meth-
ods in human skin tissue (listed in Table 1) but few of these
show skin-selective expression. Most skin chemokines are classi-
ﬁed as inﬂammatory chemokines, meaning that they are upregu-
lated under inﬂammatory conditions in order to target effector
cells. Among those associated with inﬂammatory diseases are
the CCR4 ligands CCL17 and CCL22. Both are produced by
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Table 1 | Chemokine expression in human skin.
Chemokine Receptor Type Methoda Remarksb
CCL1 CCR8 Steady state IHC/IF Vascular EC of dermal plexus; LCs and melanocytes (Schaerli et al., 2004)
Tissue culture PCR/RNase
PA/IHC/ELISA
Dermal vascular EC and resting Langerhans-type DC; activated mast cells, skin T cells
and dermal ﬁbroblasts (Schaerli et al., 2004; Gombert et al., 2005; Ebert et al., 2006;
Hintzen, 2008)
Inﬂamed PCR Allergic contact dermatitis (Sebastiani et al., 2001; Gombert et al., 2005; Gros et al., 2009)
CCL17/CCL22 CCR4 Steady state IF Low levels of CCL17 detected in dermal vessels of non-inﬂamed skin (Chong et al., 2004)
Tissue culture PCR/ELISA Keratinocytes; dermal ﬁbroblasts stimulated by inﬂammatory cytokines (Vestergaard
et al., 2000; Albanesi et al., 2001; Horikawa et al., 2002; Yu et al., 2002; Fukuda et al.,
2003; Sumiyoshi et al., 2003)
Inﬂamed PCR/ISH/
microarray/IHC
AD (Vestergaard et al., 2000; Goebeler et al., 2001; D’Ambrosio et al., 2002; Horikawa
et al., 2002; Martin et al., 2002; Sebastiani et al., 2002; Uchida et al., 2002; Zheng et al.,
2003; Echigo et al., 2004; Guttman-Yassky et al., 2007; Gros et al., 2009; Kamsteeg et al.,
2010)
IHC Psoriasis (Rottman et al., 2001)
PCR/IHC CutaneousT and B lymphoma (Ferenczi et al., 2002;Yoshie et al., 2002; Kakinuma et al.,
2003b; Ishida et al., 2005; Harasawa et al., 2006)
IHC/ELISA Cutaneous lupus erythematosus (Wenzel et al., 2005)
PCR/IHC Drug-induced maculopapular exanthema (Tapia et al., 2007)
CCL20 CCR6 Steady state PCR/IHC Constitutive low levels in basal epidermis; keratinocytes and dermal vascular EC
(Charbonnier et al., 1999; Homey et al., 2000; Schmuth et al., 2002)
Tissue culture PCR/ELISA Keratinocytes, melanocytes, dermal vascular and lymph. ECs and ﬁbroblasts upon stim-
ulation with inﬂammatory mediators (cytokines, TLRs, SAgetc), anti-microbial peptides,
or allergens (Dieu-Nosjean et al., 2000; Homey et al., 2000, 2007; Kriehuber et al., 2001;
Nakayama et al., 2001;Tohyama et al., 2001; Schmuth et al., 2002; Giustizieri et al., 2004;
Meller et al., 2005; Spiekstra et al., 2005; Niyonsaba et al., 2007; Harper et al., 2009;
Olaru and Jensen, 2010)
Function MemoryT cell arrest on activated dermal EC (Fitzhugh et al., 2000; Ghannam et al., 2011)
Inﬂamed PCR/ISH/RNA
dot blot/IHC
Psoriasis (Charbonnier et al., 1999; Schmuth et al., 2002; Gombert et al., 2005; Keller
et al., 2005; Kim et al., 2007)
PCR/IHC AD (Nakayama et al., 2001; Schmuth et al., 2002); sensitized ACD patients (Meller et al.,
2007)
IHC Behcets and AGEP (Keller et al., 2005)
PCR Mycosis fungoides; cutaneous GvHD (Schmuth et al., 2002)
IHC/IF Langerhans cell histiocytosis (Annels et al., 2003; Fleming et al., 2003)
PCR Lesions of lyme borreliosis (Mullegger et al., 2007)
PCR/IHC Drug-induced maculopapular exanthema (Fernandez et al., 2008)
CCL27 CCR10 Steady state PCR/Northern/
IHC
Primary basal keratinocytes (Morales et al., 1999; Homey et al., 2000, 2002; Humphreys
et al., 2005; Meller et al., 2005)
Tissue culture Microarray/IF Podoplanin-low dermal lymphatic EC (Wick et al., 2008)
PCR Generally induced by IL-1β andTNF-α; inhibited by prostaglandin E2 (Homey et al., 2000,
2002; Kanda et al., 2004; Meller et al., 2005)
Inﬂamed IHC AD and Psoriasis (Homey et al., 2002; Kakinuma et al., 2003a; Hijnen et al., 2004;
Campanati et al., 2007)
PCR/IHC Drug-induced maculopapular exanthema (Tapia et al., 2004; Fernandez et al., 2008)
PCR Skin lesions of systemic sclerosis (Hayakawa et al., 2005)
IHC Cutaneous lupus erythematosus (Meller et al., 2005)
IHC Skin-affected GvHD (Faaij et al., 2006)
microarray/IHC Infections (Haemophilus ducreyi ; Staphylococcus aureus; Humphreys et al., 2005;
Holland et al., 2009)
PCR ATLL skin lesions (Harasawa et al., 2006)
PCR/IHC Malignant skin tumors (Kai et al., 2011); not conﬁrmed in (Pivarcsi et al., 2007)
(Continued)
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Table 1 | Continued
Chemokine Receptor Type Methoda Remarksb
CCL28 CCR10 Steady state RNA dot
blot/Northern
Normal skin but at much lower levels than CCL27 (Pan et al., 2000)
Tissue culture PCR/ELISA TNF-α+ IL-1β-stimulated HaCaT (Kanda et al., 2005)
Inﬂamed PCR ATLL skin lesions (Harasawa et al., 2006)
CXCL12 CXCR4 Steady state PCR/ISH/IHC/
IF/WB
Blood ECs of superﬁcial dermal plexus, sweat glands, keratinocytes, DC/LC and ﬁbrob-
lasts (Pablos et al., 1999; Fedyk et al., 2001; Gombert et al., 2005; Avniel et al., 2006;
Cipriani et al., 2006; Narducci et al., 2006; Chen et al., 2009)
Inﬂamed PCR/ISH Scleroderma; cutaneous lupus erythematosus; dermatomyositis (Pablos et al., 1999;
Meller et al., 2005)
IHC AD (Gombert et al., 2005; Meller et al., 2007)
ISH/IHC Cutaneous lesions of pDC leukemia (Bendriss-Vermare et al., 2004)
IHC/WB Cutaneous Kaposi’s sarcoma lesions (Yao et al., 2003)
ISH/IHC Metastatic melanoma (Vermi et al., 2003); Neoplastic CTCL (Sezary syndrome and
mycosis fungoides; Narducci et al., 2006)
IF Dermal lymphatic EC in Paget’s disease (Hirakawa et al., 2009)
IHC Apocrine-assoc. cutaneous tumors; not detected in non-glandular or follicular tumors
(Chen et al., 2009)
ISH/IHC/ELISA Margin of burn and incisional wounds (Avniel et al., 2006; Toksoy et al., 2007)
CXCL14 Unknown Steady state ISH/Northern/
PCR/IHC
Epidermis and squamous epithelium; blood EC; basal keratinocytes and dermal
macrophages and mast cells (Frederick et al., 2000; Kurth et al., 2001; Schaerli et al.,
2005; Meuter and Moser, 2008)
Tissue culture PCR LPS-stimulated B cells and monocytes (Frederick et al., 2000)
Northern/PCR Loss in epithelial cell lines, and TNF-α+ IL-1β-stimulated keratinocytes and adherent
dermal cells (Kurth et al., 2001; Schaerli et al., 2005)
Inﬂamed ISH/IHC Loss in AD; Psoriasis; squamous cell carcinoma (Frederick et al., 2000; Kurth et al., 2001;
Shellenberger et al., 2004; Shurin et al., 2005)
CXCL16 CXCR6 Steady state IHC/IF Low levels keratinocytes and blood EC (Scholz et al., 2007; Tohyama et al., 2007)
Tissue culture PCR/ELISA Keratinocytes and dermal EC upon activation with pro-inﬂammatory mediators (Scholz
et al., 2007; Tohyama et al., 2007; Chen et al., 2011)
Inﬂamed IHC Cytoplasmic CXCL16 in basal keratinocytes of Psoriasis (Oh et al., 2009)
CX3CL1 CX3CR1 Steady state IHC/IF Epidermis, keratinocytes (Lucas et al., 2001; Sugaya et al., 2003); LC; melanocytes;
dermal plexus EC (Ab cross-reacting with CD84; Papadopoulos et al., 1999)
Tissue culture PCR/WB Migratory LC; TNF-α and IFNγ-stimulated keratinocytes, dermal ﬁbroblasts, dermal EC
line (Papadopoulos et al., 1999; Raychaudhuri et al., 2001; Fahy et al., 2003; Chen et al.,
2011)
Inﬂamed PCR/IHC Psoriasis (keratinocytes and blood EC; Fraticelli et al., 2001; Raychaudhuri et al., 2001;
Sugaya et al., 2003; Echigo et al., 2004; Nakayama et al., 2010)
PCR/IHC Lesional AD (blood EC; Echigo et al., 2004; Nakayama et al., 2010)
IHC Cutaneous systemic sclerosis (blood EC; Hasegawa et al., 2005)
PCR/IHC Lichen planus lesions (Raychaudhuri et al., 2001; Sugaya et al., 2003)
IHC/FC Melanoma biopsies and cell lines (Izraely et al., 2010)
aAbbreviations: IHC, immunohistochemistry; IF, immunoﬂuorescence; ISH, in situ hybridization; FC, ﬂow cytometry; RNase PA, RNase protection assay;WB,Western
blot.
bAbbreviations: AD, atopic dermatitis; ACD, allergic contact dermatitis; AGEP, acute generalized exanthematous pustulosis; ATLL, adult T-cell leukemia/lymphoma;
CTCL, cutaneousT-cell lymphoma; EC, endothelial cells; GvHD, graft versus host disease; LC, Langerhans cells; LPS, lipopolysaccharide; pDC, plasmacytoid dendritic
cell; SAg, superantigen; TLR, Toll-like receptor.
epidermal keratinocytes and dermal ﬁbroblasts in response to
inﬂammatory signals (Vestergaard et al., 2000; Albanesi et al.,
2001; Horikawa et al., 2002; Fukuda et al., 2003), and are promi-
nently associated with atopic dermatitis (Vestergaard et al., 2000;
Goebeler et al., 2001; D’Ambrosio et al., 2002; Horikawa et al.,
2002; Sebastiani et al., 2002; Uchida et al., 2002; Zheng et al.,
2003; Echigo et al., 2004; Guttman-Yassky et al., 2007; Gros
et al., 2009; Kamsteeg et al., 2010), Psoriasis (Rottman et al.,
2001), and cutaneous lymphomas (Ferenczi et al., 2002; Yoshie
et al., 2002; Kakinuma et al., 2003b; Ishida et al., 2005). In
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addition to skin, CCL17/22 have been detected at elevated lev-
els in the lung mucosa of asthmatics (Panina-Bordignon et al.,
2001; Bochner et al., 2003). Additionally, CCR4+ T cells have
been identiﬁed in inﬂammatory conditions affecting the syn-
ovium (Leipe et al., 2010), lung (Panina-Bordignon et al., 2001;
Nouri-Aria et al., 2002; Vijayanand et al., 2010), liver (Oo et al.,
2010), peritoneum and appendix (Michelle L. McCully and Bern-
hard Moser, unpublished observations), indicating that CCR4
aids the non-selective migration of effectors to many inﬂamed
sites. In mice, early studies implicated CCR4 as being critical
for the migration of antigen-speciﬁc effector cells and Tregs to
inﬂamed skin (Reiss et al., 2001; Campbell et al., 2007), but more
recent studies found that skin inﬂammatory responses were intact
or even elevated in the absence of CCR4 expression (Lehtimaki
et al., 2010; Sells and Hwang, 2010) underlining the signiﬁ-
cant amount of redundancy in the chemokine network during
inﬂammation.
Similar to CCL17 (see above), CCL20, the single ligand of
CCR6, is barely detectable in healthy skin but increases substan-
tially with inﬂammation (Charbonnier et al., 1999; Homey et al.,
2000; Schmuth et al., 2002). Increased CCL20 expression has been
detected in several cutaneous inﬂammatory disorders (Table 1),
notably Psoriasis (Charbonnier et al., 1999; Schmuth et al., 2002;
Gombert et al., 2005; Keller et al., 2005; Kim et al., 2007). Relevant
to the present discussion, CCL20 (as well as CCL17), have been
detected at low levels in normal skin. CCL20 expression in the epi-
dermis and on lymphatic endothelium has been proposed to reg-
ulate the constitutive migration of CCR6+ LCs and DC precursors
(Charbonnier et al., 1999) whereas CCL17 expression in dermal
blood vessels was suggested to facilitate trans-endothelial migra-
tion of circulatingCCR4+ cells (Campbell et al., 1999;Chong et al.,
2004).
A prominent role for CXCL12 in skin-selective homing of
immune cells is unlikely due to its ubiquitous tissue distribu-
tion and the fact that its speciﬁc receptor CXCR4 is expressed on
all circulating leukocytes. Evidence for a role of the membrane-
bound chemoattractant CXCL16, the single ligand for CXCR6, in
human skin immunity is relatively recent and includes constitu-
tive expression on keratinocytes, and blood endothelia (Scholz
et al., 2007; Tohyama et al., 2007). However, its expression is
substantially increased in response to pro-inﬂammatory stim-
uli and, in addition to skin, CXCL16 is found in healthy lung
parenchyma as well as inﬂammatory sites within the lung (Mor-
gan et al., 2005), liver (Heydtmann et al., 2005), and colon
(Diegelmann et al., 2010), precluding its involvement in tissue-
selective homing. A second membrane-bound chemoattractant,
CX3CL1, the single ligand for CX3CR1, was originally found in
the epidermis (Papadopoulos et al., 1999; Sugaya et al., 2003);
however, using a more selective antibody reagent, expression of
CX3CL1 in healthy skin could not be conﬁrmed (Lucas et al.,
2001; Echigo et al., 2004), whereas its expression was readily
detected in many cutaneous inﬂammatory lesions (Fraticelli et al.,
2001; Raychaudhuri et al., 2001; Sugaya et al., 2003; Echigo et al.,
2004; Hasegawa et al., 2005; Izraely et al., 2010; Nakayama et al.,
2010).
This leaves three potential chemokine candidates, CCL27,
CCL1, and CXCL14, for regulating the trafﬁcking of skin-homing
lymphocytes. CCL27 is selectively produced by epidermal ker-
atinocytes and controls the migration of CCR10+ T cells to
the epidermal compartment (Morales et al., 1999; Sigmunds-
dottir et al., 2007). In blood of healthy donors, CCR10+ T cells
make up a signiﬁcant proportion of CLA+ T cells (Hudak et al.,
2002), whereas in healthy skin, CCR10+ cells were not detected
(Michelle L. McCully and Bernhard Moser, unpublished observa-
tions), arguing against a role for CCL27 in controlling cutaneous
T cell trafﬁc under steady-state conditions. Epidermal CCL27 pro-
duction is signiﬁcantly increased in response to inﬂammatory
mediators and is prominently present in cutaneous inﬂamma-
tory lesions (listed in Table 1). In support of an inﬂammatory
role, CCL27–CCR10 was found to regulate T cell recruitment
to the epidermis in mouse models of acute skin inﬂammation
(Reiss et al., 2001; Homey et al., 2002). Of interest, CCR10+ cells
are also targeted by CCL28, which is widely expressed by many
mucosal tissues (Pan et al., 2000), which were shown to harbor
CCR10+ T cells, and B cells (Eksteen et al., 2006; Morteau et al.,
2008), arguing against a contribution to a skin-selective address
code.
CXCL14andCCL1are two chemokines that are readily detected
in healthy human skin. CCL1 and its receptor CCR8 are dis-
cussed separately in the next chapter. CXCL14 is constitutively
expressed in epidermal and squamous epithelial tissues (Meuter
and Moser, 2008). In skin, CXCL14 is mainly produced by basal
keratinocytes, but expression has also been detected on dermal
endothelial cells, macrophages, and mast cells (Kurth et al., 2001;
Schaerli et al., 2005;Meuter andMoser,2008).Of note, the produc-
tion of this chemokine by keratinocytes was very high, allowing for
its puriﬁcation from natural sources in quantities large enough for
functional studies. The receptor for CXCL14 has yet to be identi-
ﬁed, but chemotaxis assays have implicated CXCL14 in the speciﬁc
mobilization of monocytes (Kurth et al., 2001), NK cells (Starnes
et al., 2006), and human, but not mouse, dendritic cell precur-
sors (Schaerli et al., 2005; Starnes et al., 2006; Meuter et al., 2007).
CXCL14 does not act on T cells and, therefore, does not play a
role in controlling immune surveillance T cells in healthy human
skin. Numerous additional inﬂammatory chemokines not listed in
Table 1 are also known to be produced in diseased skin, but have
been excluded here as they are known to be produced in many
other inﬂamed tissues and thus, cannot account for skin-speciﬁc
immune cell trafﬁc.
DOES CCL1-CCR8 PLAY A ROLE IN SKIN IMMUNITY?
Today, CCL1–CCR8 is one of the least understood chemokine sys-
temdespite the fact thatCCL1 (formerly knownas I-309 andTCA3
in human and mouse, respectively) was the ﬁrst among a long
succession of CC chemokines to be discovered (Burd et al., 1987;
Miller et al., 1989). The cDNA cloning strategy, based on RNA
extracted from human and mouse T cells, already indicated that
CCL1 may target T cells; and activated T cells secrete up to large
amounts of CCL1,whereas its production by tissue cells appears to
be less prominent (Table 2). CCL1 is not a bona ﬁde inﬂammatory
chemokine since its expression in the presence of inﬂammatory
stimuli is controversial. Besides activated T cells, human immune
cells reported to produce CCL1 mRNA, and/or protein include
mast cells and DCs. In skin, CCL1 is produced by cultured T cells
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Table 2 | Expression of human CCL1 and CCR8.
Expression Method Remarks
CCL1 T cells mRNA, ELISA Original cloning (Miller et al., 1989); in vitro Th1 and Th2 cells (Sallusto et al., 1999);
skin-derivedT cells (Schaerli et al., 2004)
Monocytes
dendritic cells
mRNA,
immunoprecipitation
Cultured blood monocytes (Selvan et al., 1997)
Mast cells mRNA, IHC, ELISA,
immunoprecipitation
Activated, cord blood-derived (Nakajima et al., 2002; Gonzalo et al., 2007); mast cell
leukemia (Selvan et al., 1994)
Keratinocytes mRNA After activation (Albanesi et al., 2001); but not found by (Gombert et al., 2005)
Endothelial cells IHC, western blot Activated HUVEC (Haque et al., 2000); skin endothelial cells (Gombert et al., 2005)
Thymus IHC Macrophages, epithelial cells (Annunziato et al., 2002)
Skin mRNA, IHC, ELISA LC, melanocytes, enothelial cells in healthy skin (Schaerli et al., 2004); LC, mast cells,
endothelial cells in atopic dermatitis (Gombert et al., 2005); nickel allergy (Sebastiani
et al., 2001)
Lung asthma,
allergy
mRNA, IHC, ELISA Bronchial epithelial cells, BALF (Montes-Vizuet et al., 2006); epithelial cells following RSV
infection (Zhang et al., 2001); but not found in diseased lung (Panina-Bordignon et al.,
2001; Bochner et al., 2003; Ying et al., 2008)
CCR8 T cells Flow cytometry,
function
CD4+ >CD8+ T cells, Foxp3+ Treg, Th2 and other blood CD4+ T cells cells (Soler et al.,
2006); low numbers on CLA+ cells (Clark et al., 2006); subset of PBL but no function
(Gombert et al., 2005); CD4+ >CD8+ bloodT cells, Th2 cells (Mutalithas et al., 2010)
Treg cells mRNA, function Cutaneous nickel-speciﬁc CD4+ Treg cells (Sebastiani et al., 2001); blood
CLA+CD4+CD25+ T cells (Iellem et al., 2001; Colantonio et al., 2002a)
Th2 mRNA, function Th2 clones and lines, upregulation during short-term activation (D’Ambrosio et al., 1998;
Zingoni et al., 1998; Colantonio et al., 2002b); upregulation during lateTh2 differentiation
(Colantonio et al., 2002b); IL-5 producingTh2 cells (Islam et al., 2011)
Thymocytes mRNA, ﬂow cytometry CD4+ >CD8+ (Napolitano et al., 1996; Zaballos et al., 1996; Tiffany et al., 1997; Zingoni
et al., 1998) NaturalTreg cells (CD4+CD25+, CD8+CD25+; Annunziato et al., 2002; Cosmi
et al., 2003)
NK cells mRNA, ﬂow cytometry,
function
No expression and response to CCL1 of blood NK cells (Loetscher et al., 1996); but func-
tional expression in IL-2 act. NK cells (Inngjerdingen et al., 2000, 2001); on skin but not
blood NK cells (Ebert et al., 2006)
Monocytes
dendritic cells
mRNA, functional Flow
cytometry
Chemotaxis (Miller and Krangel, 1992); and mRNA expression on blood monocytes
(Tiffany et al., 1997); not conﬁrmed by (Napolitano et al., 1996; Samson et al., 1996;
Roos et al., 1997); monocyte subsets, monocyte-derived DC and LC but no function
(Haque et al., 2000; Qu et al., 2004; Gombert et al., 2005)
Lung asthma,
allergy
IHC, ﬂow cytometry Bronchial CD4+T cells (Panina-Bordignon et al., 2001; Gonzalo et al., 2007); not conﬁrmed
in asthmatics (Ying et al., 2008); low on BALTh2 cells (Mutalithas et al., 2010)
Skin Flow cytometry CLA+, mostlyTh1 cells (Clark et al., 2006); primary skin αβT cells, γδT cells and NK cells
(Schaerli et al., 2004; Ebert et al., 2006)
as well as LCs, possiblymelanocytes andmicrovascular endothelial
cells but not by keratinocytes or dermal ﬁbroblasts (Schaerli et al.,
2004). Its expression was also associated with atopic dermatitis,
allergy, and asthma (Sebastiani et al., 2001; Zhang et al., 2001;
Gombert et al., 2005; Montes-Vizuet et al., 2006) although this
ﬁnding couldnot be conﬁrmedbyothers (Panina-Bordignon et al.,
2001; Bochner et al., 2003; Ying et al., 2008). There is no evidence
for CCL1 production by other tissues. Obviously, identiﬁcation of
CCL1 target cells is of paramount importance for understand-
ing the role played by CCL1 in physiologic and/or pathologic
conditions.
CCR8, the only receptor for CCL1, was cloned in the late 90s
(Roos et al., 1997; Tiffany et al., 1997; Goya et al., 1998). Early
mRNA expression and functional data pointed to CCR8 being
expressed by diverse subsets of T cells, including Th1, Th2, Treg
cells, and, interestingly, CD4+CD25hi thymocytes with natural
Treg function (Table 2). Expression and function of CCR8 in
monocytes, DCs, and NK cells is still controversial and this is most
likely due to paucity in CCR8-speciﬁc Abs. Some commercial Abs
turned out to lack speciﬁcity or showed cross-reactivity with sev-
eral chemokine receptors, which added to the confusion about the
CCL1 target cells.
Mice with genetic modiﬁcations provide strong models for the
in vivo study of chemokine systems. TCA3, the mouse orthologue
of humanCCL1,was originally cloned fromactivatedT cells (Burd
et al., 1987) and its receptor CCR8 was found to be expressed by
lymphocytes from blood and thymus (Zaballos et al., 1996; Goya
et al., 1998). The results from CCR8−/− mice are controversial.
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Two studies demonstrate a role for CCR8 in the control of Th2
cells and eosinophils in models of allergic lung diseases (Chen-
sue et al., 2001; Gonzalo et al., 2007), implicating mast cells as a
source of CCL1. However, these ﬁndings were contested by the
work of other laboratories (Chung et al., 2003; Goya et al., 2003;
Mikhak et al., 2009). Although a role for CCR8 in antigen-driven
lung disease remains unclear, an additional study has implicated
CCR8 in contributing to the development of chronic inﬂamma-
tion in a model of chronic Aspergillus-induced asthma (Buckland
et al., 2007). A separate line of studies has linked CCR8 signal-
ing with protection of apoptosis in mouse thymocytes (Van Snick
et al., 1996; Louahed et al., 2003; Spinetti et al., 2003), suggest-
ing a role in thymocyte development (Kremer et al., 2001). A
recent report highlights the importance of CCR8 in a mouse
model of atopic dermatitis (Islam et al., 2011). However, it is
important to note that in this model mouse CCL8, but not
mouse CCL1, was identiﬁed as the physiologically relevant ligand
for CCR8 involved in controlling Th2 mobilization, and subse-
quent skin allergy development. To complicate matters further,
human CCL8 (alias MCP-2), one of four chemokines for CCR2,
does not bind to human or mouse CCR8, highlighting funda-
mental differences in immune mechanisms between mice and
humans. Collectively, mouse CCR8 marks a subset of Th2 cells
with a potential role in allergic disease of lung and skin and,
probably, a subset of thymic CD4+ T cells. An involvement of
CCL1/CCL8 and CCR8 in gastrointestinal inﬂammation has not
been reported.
The current state in research supports our view that CCR8
marks a functionally heterogeneous population of CD4+ and
CD8+ T cells subsets featuring homing preferences for human skin
(although lung homing properties cannot be excluded at present;
Figure 2). Human skin is a vast reservoir for memory T cells under
steady-state conditions, most of which express CCR8 (Table 3).
Our previous work found that the majority of skin-resident CD4+
and CD8+ αβ T cells, (Vδ1+) γδ T cells, and a subset NK cells
stained positive for this receptor (Schaerli et al., 2004; Ebert et al.,
2006). Several reports have documented CCR8 expression on skin
LCs, DCs, and their mononuclear precursors (Haque et al., 2000;
Qu et al., 2004; Gombert et al., 2005; Gros et al., 2009), but we
were unable to conﬁrm these ﬁndings.
FIGURE 2 | CCR8+ T cells are part of the cellular immune surveillance
system in healthy human skin.This model describes the recruitment to the
skin and retention of CCR8+ memoryT cells (and possibly NK cells). The skin
address code is composed of CLA, a ligand for E/P-selectins, and CCR8, the
chemokine receptor for CCL1, both present on the luminal side of the
microvasculature within the dermal plexus. Following trans-endothelial
migration, dermal CCR8+ T cells sense CCL1 constitutively expressed by LCs
(and possibly melanocytes), and subsequent co-localization allows the
screening of LCs by CCR8+ T cells for the presence of cognate peptide-MHC
molecules. Self-peptide-presenting LCs may induce local Treg cell responses
whereas microbial peptide-presenting LCs may induce protective
anti-microbial T cell responses. In this model, CCR8 does not distinguish
between functional T cell subsets, but rather combines differentT cell subsets
that are necessary for immune surveillance of human skin in the steady state.
Tps, peripheral surveillanceT cell; EC, endothelial cell; Me, melanocyte; LC,
Langerhans cell; CLA, cutaneousT lymphocyte antigen.
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Table 3 | CCR8 in cutaneous immune cells.
Cell type Steady
state
Range
(%)
Reference
LYMPHOCYTES
CD3+ T cells + (46–54*) Clark et al. (2006)
CD4+ T cells + (36–74) Schaerli et al. (2004)
CD8+ T cells + (59–95) Schaerli et al. (2004)
γδT cells + (46–60) Ebert et al. (2006)
B cells − Schaerli et al. (2004)
NON-LYMPHOCYTES
NK cells + (<50) Ebert et al. (2006)
Monocytes/macrophages − Schaerli et al. (2004)
DCs − Schaerli et al. (2004)
*Combined ranges from all isolation techniques.
Despite being coined a marker for Th2 cells, CCR8-expressing,
skin-derived CD4+, and CD8+ T cells were biased toward the pro-
duction of the pro-inﬂammatory cytokines IFNγ, TNFα, and IL-2
after ex vivo stimulation, while the secretion of Th2-associated
cytokines (IL-4, IL-5, and IL-13) were rarely detected (Schaerli
et al., 2004; Clark et al., 2006). Additionally, CCR8-expressing
CD8+ T cells were devoid of cytolytic functions, suggesting that
CCR8+ T cells participate in local immune responses through the
secretion of pro-inﬂammatory cytokines. The fact that skin–tropic
viruses encode functional proteins targeting CCR8 further sup-
ports a role of CCR8 in skin-speciﬁc immune defense. Speciﬁcally,
the human poxvirus molluscum contagiosum encodes a selective
antagonist for CCR8, called MC148 (Luttichau et al., 2000). And
human herpes virus 8 (HHV8) encodes two viral orthologues of
the macrophage inﬂammatory protein family (vMIP-I and vMIP-
II); vMIP-I functions as a CCR8 agonist, while vMIP-II serves as
a broad-spectrum chemokine receptor antagonist (Sozzani et al.,
1998; Dairaghi et al., 1999; Endres et al., 1999).
Although CCR8 marked a signiﬁcant proportion of skin-
resident T cells in the steady state, CCR8+ cells were at present not
found (or were extremely rare) in many skin-associated inﬂam-
matory diseases (Schaerli et al., 2004; Gombert et al., 2005; Keller
et al., 2005; Ottaviani et al., 2006; Gros et al., 2009). The rele-
vance of this disparate expression (non-inﬂamed versus inﬂamed)
is currently unclear but points toward a role for CCR8 and its
ligand CCL1 in the localization of peripheral T cells and NK
cells under steady-state conditions. This is supported by the pres-
ence of CCL1 expression on the dermal microvasculature as well
as by epidermal Langerhans cells and melanocytes of healthy,
non-inﬂamed, human skin. Importantly, we did not ﬁnd CCL1
expression in keratinocytes or dermal ﬁbroblasts; two cell types
that mainly produce CXCL14 in the steady state and a multi-
tude of inﬂammatory chemokines in response to infection. Based
on these data, we propose a model whereby CCL1–CCR8 regu-
lates the homeostatic homing of peripheral immune–surveillance
T cells to human skin tissue (Figure 2). This model predicts that
the presence of low levels of CCL1 on microvascular endothe-
lial cells recruits CLA+ CCR8+ T cells to the dermis of healthy
human skin. Expression of CCL1 by LCs and/or melanocytes may
localize dermal CCR8+ T cells in close proximity of the epider-
mis. In fact, CCL1 production by LCs as opposed to the highly
abundant keratinocytes (or dermal ﬁbroblasts) ﬁts nicely with
the view of a continuous interaction between CCL1-responding
memory T cells in the dermis and peptide–MHC-presenting LCs
in the epidermis. By responding to self-peptide–MHC or micro-
bial peptide–MHC molecules, dermal CCR8+ T cells would act
as essential players in tissue homeostasis, and/or anti-microbial
immunity. This model also extends to cutaneous γδ T cells
and even NK cells, indicating that the principal role of CCL1–
CCR8 may be to regulate the co-localization of immune surveil-
lance cells in healthy skin that, collectively, guarantee skin tissue
integrity.
CONCLUDING REMARKS
As discussed above, we propose that the single chemokine, CCL1,
and its receptor CCR8 regulate the steady-state homing of long-
lived lymphocyte populations to human skin tissue. The relation-
ship between CCR8+ T cells in the skin and those in blood is not
clear at present. However, we would like to portray the view that
they differ fundamentally in terms of function. In support, in a
mouse model of cutaneous HSV infection, HSV-speciﬁc memory
T cells were shown to reside primarily in skin tissue as opposed to
blood (Wakim et al., 2008; Gebhardt et al., 2009). Although simi-
lar studies cannot be done in humans, we, and others have shown
that human skin-derived CCR8+ T cells are capable of producing
many cytokines in response to stimulation with a bias toward the
production of Th1 cytokines (Schaerli et al., 2004; Clark et al.,
2006). On the other hand, blood CCR8+ T cells preferentially
secrete Th2 type cytokines (Zingoni et al., 1998; Soler et al., 2006;
Islam et al., 2011), most notably IL-5 (Zingoni et al., 1998; Soler
et al., 2006; Islam et al., 2011). Furthermore, we wish to point out
that in addition to αβ T cells, NK cells, and γδ T cells in healthy
human skin also express CCR8, further underscoring the hetero-
geneity among CCR8+ cells. Clearly, further studies with primary
lymphocytes from human skin are required to better deﬁne their
function. It is essential that these studies be carried out using
human tissue as mouse skin differs fundamentally from human
in terms of physiology (i.e., fur, thickness, vitamin metabolism) as
well as in the types of immune cells present (DETC cells in mice
that are absent in humans). These studies also need to include
experiments focusing on the generation of CCR8+ T cells during
activation of naïve peripheral blood T cells with diverse subsets of
DCs as the factors that induce CCR8 expression in T cells have yet
to be deﬁned. What does appear to be certain at this stage is that
there exists signiﬁcant phenotypic and functional heterogeneity
among human skin CCR8+ lymphocytes, lending support to the
model whereby CCR8 marks immune surveillance cells charac-
terized by a distinct tissue tropism (skin) as opposed to a speciﬁc
effector function.
ACKNOWLEDGMENTS
In this review, we have focused on citing human research and due
to space limitations were unable to include an extensive list of
references pertaining to non-human research. Research has been
supportedby a grant from theWellcomeTrust; B.M. is the recipient
of a Royal Society Wolfson Research Merit Award.
www.frontiersin.org August 2011 | Volume 2 | Article 33 | 9
McCully and Moser Immune cell homing to the skin
REFERENCES
Agace, W. W. (2008). T-cell recruitment
to the intestinal mucosa. Trends
Immunol. 29, 514–522.
Albanesi, C., Scarponi, C., Sebas-
tiani, S., Cavani, A., Federici, M.,
Sozzani, S., and Girolomoni, G.
(2001). A cytokine-to-chemokine
axis betweenT lymphocytes and ker-
atinocytes can favor Th1 cell accu-
mulation in chronic inﬂammatory
skin diseases. J. Leukoc. Biol. 70,
617–623.
Annels, N. E., Da Costa, C. E., Prins, F.
A., Willemze, A., Hogendoorn, P. C.,
and Egeler, R. M. (2003). Aberrant
chemokine receptor expression and
chemokine production by Langer-
hans cells underlies the pathogenesis
of Langerhans cell histiocytosis. J.
Exp. Med. 197, 1385–1390.
Annunziato, F., Cosmi, L., Liotta, F.,
Lazzeri, E., Manetti, R., Vanini,
V., Romagnani, P., Maggi, E., and
Romagnani, S. (2002). Phenotype,
localization, and mechanism of
suppression of CD4(+)CD25(+)
human thymocytes. J. Exp.Med. 196,
379–387.
Avniel, S., Arik, Z., Maly, A., Sagie,
A., Basst, H. B., Yahana, M. D.,
Weiss, I. D., Pal, B., Wald, O., Ad-
El, D., Fujii, N., Arenzana-Seisdedos,
F., Jung, S., Galun, E., Gur, E., and
Peled, A. (2006). Involvement of
the CXCL12/CXCR4 pathway in the
recovery of skin following burns. J.
Invest. Dermatol. 126, 468–476.
Bendriss-Vermare, N., Chaperot, L.,
Peoc’h, M., Vanbervliet, B., Jacob,
M. C., Briere, F., Bensa, J. C.,
Caux, C., and Plumas, J. (2004).
In situ leukemic plasmacytoid den-
dritic cells pattern of chemokine
receptors expression and in vitro
migratory response. Leukemia 18,
1491–1498.
Bochner, B. S., Hudson, S. A., Xiao, H.
Q., and Liu, M. C. (2003). Release
of both CCR4-active and CXCR3-
active chemokines during human
allergic pulmonary late-phase reac-
tions. J. Allergy Clin. Immunol. 112,
930–934.
Brinkman, C. C., Sheasley-O’Neill, S.
L., Ferguson, A. R., and Engelhard,
V. H. (2008). Activated CD8 T cells
redistribute to antigen-free lymph
nodes and exhibit effector andmem-
ory characteristics. J. Immunol. 181,
1814–1824.
Buckland, K.F., O’connor, E. C., Cole-
man, E. M., Lira, S. A., Lukacs, N.
W., and Hogaboam, C. M. (2007).
Remission of chronic fungal asthma
in the absence of CCR8. J. Allergy
Clin. Immunol. 119, 997–1004.
Burd, P.R., Freeman, G. J.,Wilson, S. D.,
Berman,M.,DeKruyff,R.,Billings,P.
R., and Dorf, M. E. (1987). Cloning
and characterization of a novel T cell
activation gene. J. Immunol. 139,
3126–3131.
Campanati, A., Goteri, G., Simonetti,
O., Ganzetti, G., Giuliodori, K., Stra-
mazzotti, D., Morichetti, D., Bernar-
dini, M. L., Mannello, B., Fab-
ris, G., and Ofﬁdani, A. (2007).
CTACK/CCL27 expression in psori-
atic skin and its modiﬁcation after
administration of etanercept. Br. J.
Dermatol. 157, 1155–1160.
Campbell, J. J., Haraldsen, G., Pan,
J., Rottman, J., Qin, S., Ponath, P.,
Andrew, D. P., Warnke, R., Rufﬁng,
N., Kassam, N., Wu, L., and Butcher,
E. C. (1999). The chemokine recep-
tor CCR4 in vascular recognition by
cutaneous but not intestinal mem-
ory T cells. Nature 400, 776–780.
Campbell, J. J., O’Connell, D. J., and
Wurbel, M. A. (2007). Cutting
edge: chemokine receptor CCR4 is
necessary for antigen-driven cuta-
neous accumulation of CD4 T cells
under physiological conditions. J.
Immunol. 178, 3358–3362.
Charbonnier, A. S., Kohrgruber, N.,
Kriehuber, E., Stingl, G., Rot, A.,
and Maurer, D. (1999). Macrophage
inﬂammatory protein 3alpha is
involved in the constitutive trafﬁck-
ing of epidermal langerhans cells. J.
Exp. Med. 190, 1755–1768.
Chen, S.J., Nakahara, T., Kido, M.,
Takahara, M., Uchi, H., Takeuchi,
S., Dugu, L., Tu, Y. T., Moroi,
Y., Furue, M. (2009). Stromal cell-
derived factor 1 expression in var-
ious skin tumours. Br. J. Dermatol.
160, 710–713.
Chen, T., Guo, Z. P., Jiao, X. Y., Jia, R.
Z., Zhang, Y. H., Li, J. Y., Huang, X.
L., and Liu, H. J. (2011). Peoniﬂorin
suppresses tumor necrosis factor-
alpha induced chemokine produc-
tion in humandermalmicrovascular
endothelial cells by blocking nuclear
factor-kappaB and ERK pathway.
Arch. Dermatol. Res. 303, 351–360.
Chensue, S.W., Lukacs, N. W., Yang, T.
Y., Shang, X., Frait, K. A., Kunkel,
S. L., Kung, T., Wiekowski, M. T.,
Hedrick, J. A., Cook, D. N., Zingoni,
A., Narula, S. K., Zlotnik, A., Barrat,
F. J.,O’Garra,A.,Napolitano,M.,and
Lira, S. A. (2001). Aberrant in vivo
T helper type 2 cell response and
impaired eosinophil recruitment in
CC chemokine receptor 8 knockout
mice. J. Exp. Med. 193, 573–584.
Chong, B. F., Murphy, J. E., Kupper,
T. S., and Fuhlbrigge, R. C. (2004).
E-selectin, thymus- and activation-
regulated chemokine/CCL17, and
intercellular adhesion molecule-1
are constitutively coexpressed inder-
mal microvessels: a foundation for a
cutaneous immunosurveillance sys-
tem. J. Immunol. 172, 1575–1581.
Chung,C. D., Kuo, F., Kumer, J.,Motani,
A. S., Lawrence,C. E.,Henderson,W.
R. Jr., and Venkataraman, C. (2003).
CCR8 is not essential for the devel-
opment of inﬂammation in a mouse
model of allergic airway disease. J.
Immunol. 170, 581–587.
Cipriani, P., Franca Milia, A., Liakouli,
V., Pacini, A., Manetti, M., Marrelli,
A., Toscano, A., Pingiotti, E., Ful-
minis, A., Guiducci, S., Perricone,
R., Kahaleh, B.,Matucci-Cerinic,M.,
Ibba-Manneschi, L., and Giacomelli,
R. (2006). Differential expression of
stromal cell-derived factor 1 and its
receptor CXCR4 in the skin and
endothelial cells of systemic sclerosis
patients: pathogenetic implications.
Arthritis Rheum. 54, 3022–3033.
Clark, R.A., Chong, B., Mirchandani,
N., Brinster, N. K., Yamanaka, K.,
Dowgiert, R. K., and Kupper, T. S.
(2006). The vast majority of CLA+
T cells are resident in normal skin. J.
Immunol. 176, 4431–4439.
Colantonio, L., Iellem, A., Sinigaglia, F.,
and D’Ambrosio, D. (2002a). Skin-
homing CLA+ T cells and reg-
ulatory CD25+ T cells represent
major subsets of human peripheral
blood memory T cells migrating
in response to CCL1/I-309. Eur. J.
Immunol. 32, 3506–3514.
Colantonio, L., Recalde, H., Sinigaglia,
F., and D’Ambrosio, D. (2002b).
Modulation of chemokine receptor
expression and chemotactic respon-
siveness during differentiation of
human naive T cells into Th1 or Th2
cells.Eur. J. Immunol.32,1264–1273.
Coombes, J. L., and Siddiqui, K. R.,
Arancibia-Cárcamo, C. V., Hall, J.,
Sun, C. M., Belkaid, Y., and Powrie,
F. (2007). A functionally special-
ized population of mucosal CD103
DCs induces Foxp3 regulatoryT cells
via a TGF-beta and retinoic acid-
dependent mechanism. J. Exp. Med.
204, 1757–1764.
Cosmi, L., Liotta, F., Lazzeri, E., Fran-
calanci,M.,Angeli,R.,Mazzinghi,B.,
Santarlasci, V., Manetti, R., Vanini,
V.,Romagnani,P.,Maggi,E.,Romag-
nani, S., and Annunziato, F. (2003).
Human CD8+ CD25+ thymo-
cytes share phenotypic and func-
tional features with CD4+ CD25+
regulatory thymocytes. Blood 102,
4107–4114.
D’Ambrosio, D., Albanesi, C., Lang,
R., Girolomoni, G., Sinigaglia, F.,
and Laudanna, C. (2002). Quan-
titative differences in chemokine
receptor engagement generate diver-
sity in integrin-dependent lympho-
cyte adhesion. J. Immunol. 169,
2303–2312.
D’Ambrosio,D., Iellem,A.,Bonecchi,R.,
Mazzeo, D., Sozzani, S., Mantovani,
A., and Sinigaglia,F. (1998). Selective
up-regulation of chemokine recep-
tors CCR4 and CCR8 upon activa-
tion of polarized human type 2 Th
cells. J. Immunol. 161, 5111–5115.
Dairaghi, D.J., Fan, R. A., McMaster,
B. E., Hanley, M. R., and Schall,
T. J. (1999). HHV8-encoded vMIP-
I selectively engages chemokine
receptor CCR8. Agonist and antag-
onist proﬁles of viral chemokines. J.
Biol. Chem. 274, 21569–21574.
del Rio,M. L.,Bernhardt,G.,Rodriguez-
Barbosa, J. I., and Förster, R. (2010).
Development and functional spe-
cialization of CD103 dendritic cells.
Immunol. Rev. 234, 268–281.
Diegelmann, J., Seiderer, J., Niess,
J. H., Haller, D., Göke, B., Rei-
necker, H. C., and Brand, S. (2010).
Expression and regulation of the
chemokine CXCL16 in Crohn’s dis-
ease andmodels of intestinal inﬂam-
mation. Inﬂamm. Bowel Dis. 16,
1871–1881.
Dieu-Nosjean, M. C., Massacrier, C.,
Homey, B., Vanbervliet, B., Pin, J.
J., Vicari, A., Lebecque, S., Dezutter-
Dambuyant, C., Schmitt, D., Zlot-
nik, A., and Caux, C. (2000).
Macrophage inﬂammatory protein
3alpha is expressed at inﬂamed
epithelial surfaces and is the most
potent chemokine known in attract-
ing Langerhans cell precursors. J.
Exp. Med. 192, 705–718.
Dudda, J. C., Lembo, A., Bachtanian, E.,
Huehn, J., Siewert, C., Hamann, A.,
Kremmer, E., Förster, R., and Mar-
tin, S. F. (2005). Dendritic cells gov-
ern induction and reprogramming
of polarized tissue-selective homing
receptor patterns of T cells: impor-
tant roles for soluble factors and
tissue microenvironments. Eur. J.
Immunol. 35, 1056–1065.
Ebert, L. M., Meuter, S., and Moser,
B. (2006). Homing and func-
tion of human skin gammadelta
T cells and NK cells: relevance for
tumor surveillance. J. Immunol. 176,
4331–4336.
Echigo, T., Hasegawa, M., Shimada, Y.,
Takehara, K., and Sato, S. (2004).
Expression of fractalkine and its
receptor, CX3CR1, in atopic der-
matitis: possible contribution to
skin inﬂammation. J. Allergy Clin.
Immunol. 113, 940–948.
Edele,F.,Molenaar,R.,Gütle,D.,Dudda,
J. C., Jakob, T., Homey, B., Mebius,
R., Hornef, M., and Martin, S. F.
(2008). Cutting edge: instructive
role of peripheral tissue cells in
the imprinting of T cell homing
receptor patterns. J. Immunol. 181,
3745–3749.
Frontiers in Immunology | Chemoattractants August 2011 | Volume 2 | Article 33 | 10
McCully and Moser Immune cell homing to the skin
Eksteen, B., Miles, A., Curbishley, S.
M., Tselepis, C., Grant, A. J., Walker,
L. S., and Adams, D. H. (2006).
Epithelial inﬂammation is associ-
ated with CCL28 production and
the recruitment of regulatory T cells
expressing CCR10. J. Immunol. 177,
593–603.
Eksteen, B., Mora, J. R., Haughton, E.
L., Henderson, N. C., Lee-Turner,
L., Villablanca, E. J., Curbishley, S.
M., Aspinall, A. I., von Andrian, U.
H., and Adams, D. H. (2009). Gut
homing receptors on CD8 T cells
are retinoic acid dependent and not
maintained by liver dendritic or
stellate cells. Gastroenterology 137,
320–329.
Endres, M. J., Garlisi, C. G., Xiao, H.,
Shan, L., and Hedrick, J. A. (1999).
The Kaposi’s sarcoma-related
herpesvirus (KSHV)-encoded
chemokine vMIP-I is a speciﬁc
agonist for the CC chemokine
receptor (CCR)8. J. Exp. Med. 189,
1993–1998.
Faaij, C.M., Lankester, A. C., Spierings,
E., Hoogeboom, M., Bowman, E.
P., Bierings, M., Révész, T., Egeler,
R. M., van Tol, M. J., and Annels,
N. E. (2006). A possible role for
CCL27/CTACK-CCR10 interaction
in recruiting CD4 T cells to skin in
human graft-versus-host disease. Br.
J. Haematol. 133, 538–549.
Fahy, O.L., Coates, N. J., and McColl,
S. R. (2003). Inhibition of cytokine-
induced fractalkine production by
bacterial invasion of human-dermal
ﬁbroblasts. Lab. Invest. 83, 721–730.
Fedyk, E.R., Jones, D., Critchley, H.
O., Phipps, R. P., Blieden, T. M.,
and Springer, T. A. (2001). Expres-
sion of stromal-derived factor-1 is
decreased by IL-1 and TNF and in
dermal wound healing. J. Immunol.
166, 5749–5754.
Ferenczi, K., Fuhlbrigge, R. C., Pinkus,
J., Pinkus, G. S., and Kupper, T. S.
(2002). Increased CCR4 expression
in cutaneous T cell lymphoma. J.
Invest. Dermatol. 119, 1405–1410.
Fernandez, T. D., Mayorga, C., Torres,
M. J.,Cornejo-Garcia, J.A.,López,S.,
Chaves, P., Rondon, C., and Blanca,
M. (2008). Cytokine and chemokine
expression in the skin from patients
with maculopapular exanthema to
drugs. Allergy 63, 712–719.
Fitzhugh, D. J., Naik, S., Gonzalez, E.,
Caughman, S. W., and Hwang, S.
T. (2000). CC chemokine receptor
6 (CCR6) is a marker for mem-
ory T cells that arrest on acti-
vated human dermal microvascular
endothelium under shear stress. J.
Invest. Dermatol. 115, 332.
Fleming, M. D., Pinkus, J. L., Fournier,
M. V., Alexander, S. W., Tam, C.,
Loda, M., Sallan, S. E., Nichols, K.
E., Carpentieri, D. F., Pinkus, G. S.,
and Rollins, B. J. (2003). Coinci-
dent expression of the chemokine
receptorsCCR6 andCCR7bypatho-
logic Langerhans cells in Langer-
hans cell histiocytosis. Blood 101,
2473–2475.
Fraticelli, P., Sironi, M., Bianchi, G.,
D’Ambrosio, D., Albanesi, C., Stop-
pacciaro, A., Chieppa, M., Allavena,
P., Ruco, L., Girolomoni, G., Sini-
gaglia, F., Vecchi, A., and Mantovani,
A. (2001). Fractalkine (CX3CL1) as
an ampliﬁcation circuit of polarized
Th1 responses. J. Clin. Invest. 107,
1173–1181.
Frederick, M. J., Henderson, Y., Xu,
X., Deavers, M. T., Sahin, A. A.,
Wu, H., Lewis, D. E., El-Naggar,
A. K., and Clayman, G. L. (2000).
In vivo expression of the novel
CXC chemokine BRAK in normal
and cancerous human tissue. Am. J.
Pathol. 156, 1937–1950.
Fukuda, K., Fujitsu, Y., Seki, K., Kuma-
gai, N., and Nishida, T. (2003).
Differential expression of thymus-
and activation-regulated chemokine
(CCL17) and macrophage-derived
chemokine (CCL22) by human
ﬁbroblasts from cornea, skin, and
lung. J. Allergy Clin. Immunol. 111,
520–526.
Gebhardt, T., Wakim, L. M., Eidsmo,
L., Reading, P. C., Heath, W. R.,
and Carbone, F. R. (2009). Mem-
ory T cells in nonlymphoid tissue
that provide enhanced local immu-
nity during infection with herpes
simplex virus. Nat. Immunol. 10,
524–530.
Ghannam, S., Dejou, C., Pedretti, N.,
Giot, J. P., Dorgham, K., Boukhad-
daoui,H.,Deleuze,V., Bernard, F. X.,
Jorgensen, C., Yssel, H., and Pène, J.
(2011). CCL20 and beta-defensin-2
induce arrest of human Th17 cells
on inﬂamed endothelium in vitro
under ﬂow conditions. J. Immunol.
186, 1411–1420.
Giustizieri, M. L., Albanesi, C., Fluhr,
J., Gisondi, P., Norgauer, J., and
Girolomoni, G. (2004). H1 hist-
amine receptor mediates inﬂam-
matory responses in human ker-
atinocytes. J. Allergy Clin. Immunol.
114, 1176–1182.
Goebeler, M., Trautmann, A., Voss,
A., Bröcker, E. V., Toksoy, A., and
Gillitzer, R. (2001). Differential and
sequential expression of multiple
chemokines during elicitation of
allergic contact hypersensitivity.Am.
J. Pathol. 158, 431–440.
Gombert, M., Dieu-Nosjean, M. C.,
Winterberg, F., Bünemann, E., Kub-
itza, R. C., Da Cunha, L., Haahtela,
A., Lehtimäki, S., Müller, A., Rieker,
J., Meller, S., Pivarcsi, A., Koreck, A.,
Fridman, W. H., Zentgraf, H. W.,
Pavenstädt, H., Amara, A., Caux, C.,
Kemeny,L.,Alenius,H.,Lauerma,A.,
Ruzicka, T., Zlotnik, A., and Homey,
B. (2005). CCL1-CCR8 interactions:
an axis mediating the recruitment
of T cells and Langerhans-type
dendritic cells to sites of atopic
skin inﬂammation. J. Immunol. 174,
5082–5091.
Gonzalo, J.A., Qiu, Y., Lora, J. M., Al-
Garawi, A.,Villeval, J. L., Boyce, J. A.,
Martinez-A, C., Marquez, G., Goya,
I., Hamid,Q., Fraser, C. C., Picarella,
D., Cote-Sierra, J., Hodge, M. R.,
Gutierrez-Ramos, J. C., Kolbeck, R.,
and Coyle, A. J. (2007). Coordinated
involvement of mast cells and T cells
in allergic mucosal inﬂammation:
critical role of theCC chemokine lig-
and 1:CCR8 axis. J. Immunol. 179,
1740–1750.
Goya, I., Gutiérrez, J., Varona, R., Kre-
mer, L., Zaballos, A., and Márquez,
G. (1998). Identiﬁcation of CCR8 as
the speciﬁc receptor for the human
beta-chemokine I-309: cloning
and molecular characterization of
murine CCR8 as the receptor for
TCA-3. J. Immunol. 160, 1975–1981.
Goya, I.,Villares,R.,Zaballos,A.,Gutiér-
rez, J., Kremer, L., Gonzalo, J. A.,
Varona,R.,Carramolino,L., Serrano,
A., Pallarés, P., Criado, L. M., Kol-
beck, R., Torres, M., Coyle, A. J.,
Gutiérrez-Ramos, J. C., Martínez-
A, C., and Márquez, G. (2003).
Absence of CCR8 does not impair
the response to ovalbumin-induced
allergic airway disease. J. Immunol.
170, 2138–2146.
Gros, E., Bussmann, C., Bieber, T.,
Förster, I., and Novak, N. (2009).
Expression of chemokines and
chemokine receptors in lesional and
nonlesional upper skin of patients
with atopic dermatitis. J. Allergy
Clin. Immunol. 124, 753–760 e1.
Guilliams, M., and Crozat, K., Henri, S.,
Tamoutounour, S., Grenot, P., Dev-
ilard, E., de Bovis, B., Alexopoulou,
L., Dalod, M., and Malissen, B.
(2010). Skin-draining lymph nodes
contain dermis-derived CD103(−)
dendritic cells that constitutively
produce retinoic acid and induce
Foxp3(+) regulatory T cells. Blood
115, 1958–1968.
Guttman-Yassky, E., Lowes, M. A.,
Fuentes-Duculan, J., Whynot, J.,
Novitskaya, I., Cardinale, I., Haider,
A., Khatcherian, A., Carucci, J. A.,
Bergman, R., and Krueger, J. G.
(2007). Major differences in inﬂam-
matory dendritic cells and their
products distinguish atopic dermati-
tis from Psoriasis. J. Allergy Clin.
Immunol. 119, 1210–1217.
Hammerschmidt, S.I., Ahrendt, M.,
Bode, U., Wahl, B., Kremmer, E.,
Förster, R., and Pabst, O. (2008).
Stromalmesenteric lymphnode cells
are essential for the generation of
gut-homing T cells in vivo. J. Exp.
Med. 205, 2483–2490.
Haque, N.S., Zhang, X., French, D. L.,
Li, J., Poon, M., Fallon, J. T., Gabel,
B. R., Taubman, M. B., Koschin-
sky, M., and Harpel, P. C. (2000).
CC chemokine I-309 is the principal
monocyte chemoattractant induced
by apolipoprotein (a) in human vas-
cular endothelial cells. Circulation
102, 786–792.
Harasawa, H., Yamada, Y., Hieshima,
K., Jin, Z., Nakayama, T., Yoshie, O.,
Shimizu, K., Hasegawa, H., Hayashi,
T., Imaizumi, Y., Ikeda, S., Soda,
H., Soda, H., Atogami, S., Takasaki,
Y., Tsukasaki, K., Tomonaga, M.,
Murata, K., Sugahara, K., Tsuruda,
K., and Kamihira, S. (2006). Survey
of chemokine receptor expression
reveals frequent co-expression of
skin-homing CCR4 and CCR10 in
adult T-cell leukemia/lymphoma.
Leuk. Lymphoma 47,
2163–2173.
Harper, E. G.,Guo,C., Rizzo,H., Lillis, J.
V., Kurtz, S. E., Skorcheva, I., Purdy,
D., Fitch, E., Iordanov, M., and
Blauvelt, A. (2009). Th17 cytokines
stimulate CCL20 expression in ker-
atinocytes in vitro and in vivo: impli-
cations for Psoriasis pathogenesis. J.
Invest. Dermatol. 129, 2175–2183.
Hasegawa,M., Sato, S., Echigo, T.,Ham-
aguchi, Y., Yasui, M., and Takehara,
K. (2005). Up regulated expression
of fractalkine/CX3CL1 andCX3CR1
in patients with systemic sclerosis.
Ann. Rheum. Dis. 64, 21–28.
Hayakawa, I., Hasegawa, M., Mat-
sushita, T., Yanaba, K., Kodera, M.,
Komura, K., Takehara, K., and Sato,
S. (2005). Increased cutaneous T-
cell-attracting chemokine levels in
sera from patients with systemic
sclerosis. Rheumatology (Oxford) 44,
873–878.
Heydtmann, M., Lalor, P. F., Eksteen,
J. A., Hübscher, S. G., Briskin,
M., and Adams, D. H. (2005).
CXC chemokine ligand 16 promotes
integrin-mediated adhesion of liver-
inﬁltrating lymphocytes to cholan-
giocytes and hepatocytes within the
inﬂamed human liver. J. Immunol.
174, 1055–1062.
www.frontiersin.org August 2011 | Volume 2 | Article 33 | 11
McCully and Moser Immune cell homing to the skin
Hijnen, D., De Bruin-Weller, M.,
Oosting, B., Lebre, C., De Jong,
E., Bruijnzeel-Koomen, C., and
Knol, E. (2004). Serum thymus
and activation-regulated chemokine
(TARC) and cutaneous T cell-
attracting chemokine (CTACK) lev-
els in allergic diseases: TARC and
CTACK are disease-speciﬁc markers
for atopic dermatitis. J. Allergy Clin.
Immunol. 113, 334–340.
Hintzen, C. (2008). Oncostatin M-
induced and constitutive activation
of the JAK2/STAT5/CIS pathway
suppresses CCL1, but not CCL7
and CCL8, chemokine expression. J.
Immunol. 181, 7341–7349.
Hirakawa, S., Detmar, M., Kerjaschki,
D., Nagamatsu, S., Matsuo, K., Tane-
mura, A., Kamata, N., Higashikawa,
K., Okazaki, H., Kameda, K.,
Nishida-Fukuda, H., Mori, H.,
Hanakawa, Y., Sayama, K., Shi-
rakata, Y., Tohyama, M., Tokumaru,
S., Katayama, I., and Hashimoto,
K. (2009). Nodal lymphangiogene-
sis and metastasis: role of tumor-
induced lymphatic vessel activation
in extramammary Paget’s disease.
Am. J. Pathol. 175, 2235–2248.
Holland, D. B., Bojar, R. A., Farrar,
M. D., and Holl, K. T. (2009). Dif-
ferential innate immune responses
of a living skin equivalent model
colonized by Staphylococcus epi-
dermidis or Staphylococcus aureus.
FEMS Microbiol. Lett. 290, 149–155.
Homey, B., Alenius, H., Müller, A.,
Soto, H., Bowman, E. P., Yuan, W.,
McEvoy,L., Lauerma,A. I.,Assmann,
T., Bünemann, E., Lehto, M., Wolff,
H., Yen, D., Marxhausen, H., To, W.,
Sedgwick, J., Ruzicka, T., Lehmann,
P., and Zlotnik, A. (2002). CCL27-
CCR10 interactions regulate T cell-
mediated skin inﬂammation. Nat.
Med. 8, 157–165.
Homey, B., Meller, S., Savinko, T.,
Alenius, H., and Lauerma, A.
(2007). Modulation of chemokines
by staphylococcal superantigen in
atopic dermatitis. Chem. Immunol.
Allergy 93, 181–194.
Homey, B., Wang, W., Soto, H.,
Buchanan, M. E., Wiesenborn, A.,
Catron, D., Müller, A., McClana-
han, T. K., Dieu-Nosjean, M.
C., Orozco, R., Ruzicka, T.,
Lehmann, P., Oldham, E., and
Zlotnik, A. (2000). Cutting edge:
the orphan chemokine receptor
G protein-coupled receptor-2
(GPR-2, CCR10) binds the skin-
associated chemokine CCL27
(CTACK/ALP/ILC). J. Immunol.
164, 3465–3470.
Horikawa, T., Nakayama, T., Hikita,
I., Yamada, H., Fujisawa, R., Bito,
T., Harada, S., Fukunaga, A.,
Chantry, D., Gray, P. W., Morita,
A., Suzuki, R., Tezuka, T., Ichihashi,
M., and Yoshie, O. (2002). IFN-
gamma-inducible expression
of thymus and activation-
regulated chemokine/CCL17
and macrophage-derived
chemokine/CCL22 in epider-
mal keratinocytes and their roles in
atopic dermatitis. Int. Immunol. 14,
767–773.
Hudak, S., Hagen, M., Liu, Y., Catron,
D., Oldham, E., McEvoy, L. M., and
Bowman, E. P. (2002). Immune sur-
veillance and effector functions of
CCR10(+) skin homing T cells. J.
Immunol. 169, 1189–1196.
Humphreys, T. L., Baldridge, L. A.,
Billings, S. D., Campbell, J. J., and
Spinola, S. M. (2005). Trafﬁcking
pathways and characterization of
CD4 and CD8 cells recruited to
the skin of humans experimentally
infected with Haemophilus ducreyi.
Infect. Immun. 73, 3896–3902.
Iellem, A., Mariani, M., Lang, R.,
Recalde, H., Panina-Bordignon, P.,
Sinigaglia, F., and D’Ambrosio,
D. (2001). Unique chemotactic
response proﬁle and speciﬁc expres-
sion of chemokine receptors CCR4
andCCR8 byCD4(+)CD25(+) reg-
ulatory T cells. J. Exp. Med. 194,
847–853.
Iliev, I. D., Mileti, E., Matteoli, G., Son-
zogni, A., Sampietro, G. M., Fos-
chi, D., Caprioli, F., Viale, G., and
Rescigno,M. (2009). Human intesti-
nal epithelial cells promote the dif-
ferentiation of tolerogenic dendritic
cells. Gut 58, 1481–1489.
Inngjerdingen, M., Damaj, B., and
Maghazachi, A. A. (2000). Human
NK cells express CC chemokine
receptors 4 and 8 and respond to
thymus and activation-regulated
chemokine, macrophage-derived
chemokine, and I-309. J. Immunol.
164, 4048–4054.
Inngjerdingen,M., Damaj, B., and Mag-
hazachi, A. A. (2001). Expression
and regulation of chemokine recep-
tors in human natural killer cells.
Blood 97, 367–375.
Ishida, T., Inagaki, H., Kusumoto, S.,
Inagaki, A., Komatsu, H., Iida, S.,
Harada, S., Takeuchi, G., and Uedaa,
R. (2005). CC chemokine receptor
4-positive diffuse large B-cell lym-
phoma involving the skin: a case
report. Int. J. Hematol. 82, 148–151.
Islam, S. A., Chang, D. S., Colvin, R.
A., Byrne, M. H., McCully, M. L.,
Moser, B., Lira, S. A., Charo, I. F., and
Luster, A. D. (2011). Mouse CCL8,
a CCR8 agonist, promotes atopic
dermatitis by recruiting IL-5+
T(H)2 cells. Nat. Immunol. 12,
167–177.
Iwata, M., and Hirakiyama, A., Eshima,
Y., Kagechika,H., Kato,C., and Song,
S. Y. (2004). Retinoic acid imprints
gut-homing speciﬁcity on T cells.
Immunity 21, 527–538.
Izraely, S., Klein, A., Sagi-Assif, O.,
Meshel, T., Tsarfaty, G., Hoon,
D. S., and Witz, I. P. (2010).
Chemokine-chemokine receptor
axes in melanoma brain metastasis.
Immunol. Lett. 130, 107–114.
Jaensson, E., and Uronen-Hansson,
H., Pabst, O., Eksteen, B., Tian,
J., Coombes, J. L., Berg, P. L.,
Davidsson, T., Powrie, F., Johansson-
Lindbom, B., and Agace, W. W.
(2008). Small intestinal CD103 den-
dritic cells display unique func-
tional properties that are conserved
between mice and humans. J. Exp.
Med. 205, 2139–2149.
Jaensson-Gyllenback, E., Kotarsky, K.,
Zapata, F., Persson, E. K., Gunder-
sen, T. E., Blomhoff, R., and Agace,
W. W. (2011). Bile retinoids imprint
intestinal CD103(+) dendritic
cells with the ability to generate
gut-tropic T cells. Mucosal Immunol.
4, 438–447.
Johansson-Lindbom, B., Svensson, M.,
Pabst,O.,Palmqvist,C.,Marquez,G.,
Förster, R., and Agace,W. W. (2005).
Functional specialization of gut
CD103 dendritic cells in the regu-
lation of tissue-selective T cell hom-
ing. J. Exp. Med. 202, 1063–1073.
Kai, H., Kadono, T., Kakinuma, T.,
Tomita, M., Ohmatsu, H., Asano,
Y., Tada, Y., Sugaya, M., and Sato, S.
(2011). CCR10 and CCL27 are over-
expressed in cutaneous squamous
cell carcinoma. Pathol. Res. Pract.
207, 43–48.
Kakinuma, T., Saeki, H., Tsunemi, Y.,
Fujita, H., Asano, N., Mitsui, H.,
Tada, Y., Wakugawa, M., Watanabe,
T., Torii, H., Komine, M., Asahina,
A., Nakamura, K., and Tamaki, K.
(2003a). Increased serum cuta-
neous T cell-attracting chemokine
(CCL27) levels in patients with
atopic dermatitis and Psoriasis
vulgaris. J. Allergy Clin. Immunol.
111, 592–597.
Kakinuma, T., Wakugawa, M., Naka-
mura, K., Hino, H., Matsushima, K.,
and Tamaki, K. (2003b). High level
of thymus and activation-regulated
chemokine in blister ﬂuid and sera of
patients with bullous pemphigoid.
Br. J. Dermatol. 148, 203–210.
Kamsteeg, M., Jansen, P. A., van
Vlijmen-Willems, I. M., van Erp,
P. E., Rodijk-Olthuis, D., van der
Valk, P. G., Feuth, T., Zeeuwen, P. L.,
and Schalkwijk, J. (2010). Molecular
diagnostics of Psoriasis, atopic der-
matitis, allergic contact dermatitis
and irritant contact dermatitis. Br.
J. Dermatol. 162, 568–578.
Kanda, N., Koike, S., and Watanabe,
S. (2005). IL-17 suppresses TNF-
alpha-induced CCL27 production
through induction of COX-2 in
human keratinocytes. J. Allergy Clin.
Immunol. 116, 1144–1150.
Kanda, N., Mitsui, H., and Watan-
abe, S. (2004). Prostaglandin E(2)
suppresses CCL27 production
through EP2 and EP3 receptors in
human keratinocytes. J. Allergy Clin.
Immunol. 114, 1403–1409.
Kang, S.G., Park, J., Cho, J. Y., Ulrich,
B., and Kim, C. H. (2011). Com-
plementary roles of retinoic acid
and TGF-beta1 in coordinated
expression of mucosal integrins by
T cells. Mucosal Immunol. 4, 66–82.
Keller, M., Spanou, Z., Schaerli, P.,
Britschgi, M., Yawalkar, N., Seitz,
M., Villiger, P. M., and Pichler, W. J.
(2005). T cell-regulated neutrophilic
inﬂammation in autoinﬂamma-
tory diseases. J. Immunol. 175,
7678–7686.
Kim, B. E., Leung, D. Y., Streib, J. E.,
Kisich, K., Boguniewicz, M., Hamid,
Q. A., and Howell, M. D. (2007).
Macrophage inﬂammatory protein
3alpha deﬁciency in atopic dermati-
tis skin and role in innate immune
response to vaccinia virus. J. Allergy
Clin. Immunol. 119, 457–463.
Kremer, L., Carramolino, L., Goya, I.,
Zaballos, A., Gutiérrez, J., Moreno-
Ortiz, M., del, C., Martínez-A, C.,
and Márquez, G. (2001). The tran-
sient expression of C-C chemokine
receptor 8 in thymus identiﬁes
a thymocyte subset committed
to become CD4+ single-positive
T cells. J. Immunol. 166, 218–225.
Kriehuber, E., Breiteneder-Geleff, S.,
Groeger, M., Soleiman, A., Schopp-
mann, S. F., Stingl, G., Kerjaschki,
D., and Maurer, D. (2001). Isolation
and characterization of dermal
lymphatic and blood endothelial
cells reveal stable and functionally
specialized cell lineages. J. Exp. Med.
194, 797–808.
Kurth, I., Willimann, K., Schaerli, P.,
Hunziker, T., Clark-Lewis, I., and
Moser, B. (2001). Monocyte selectiv-
ity and tissue localization suggests a
role for breast and kidney-expressed
chemokine (BRAK) in macrophage
development. J. Exp. Med. 194,
855–861.
Lehtimaki, S., Tillander, S., Puustinen,
A., Matikainen, S., Nyman, T.,
Fyhrquist, N., Savinko, T., Majuri,
M. L., Wolff, H., Alenius, H., and
Lauerma, A. (2010). Absence of
Frontiers in Immunology | Chemoattractants August 2011 | Volume 2 | Article 33 | 12
McCully and Moser Immune cell homing to the skin
CCR4 exacerbates skin inﬂamma-
tion in an oxazolone-induced con-
tact hypersensitivity model. J. Invest.
Dermatol. 130, 2743–2751.
Leipe, J., Grunke, M., Dechant, C.,
Reindl, C., Kerzendorf, U., Schulze-
Koops, H., and Skapenko, A. (2010).
Role of Th17 cells in human autoim-
mune arthritis. Arthritis Rheum. 62,
2876–2885.
Liu, L., Fuhlbrigge, R. C., Karibian,
K., Tian, T., and Kupper, T. S.
(2006). Dynamic programming of
CD8 T cell trafﬁcking after live
viral immunization. Immunity 25,
511–520.
Loetscher, P., Seitz, M., Clark-Lewis,
I., Baggiolini, M., and Moser, B.
(1996). Activation of NK cells by
CC chemokines. Chemotaxis, Ca2+
mobilization, and enzyme release. J.
Immunol. 156, 322–327.
Louahed, J., Struyf, S., Demoulin, J. B.,
Parmentier, M., Van Snick, J., Van
Damme, J., Renauld, J. C. (2003).
CCR8-dependent activation of the
RAS/MAPK pathway mediates anti-
apoptotic activity of I-309/CCL1
and vMIP-I. Eur. J. Immunol. 33,
494–501.
Lucas, A. D., Chadwick, N., Warren,
B. F., Jewell, D. P., Gordon, S.,
Powrie, F., and Greaves,D. R. (2001).
The transmembrane form of the
CX3CL1 chemokine fractalkine is
expressed predominantly by epithe-
lial cells in vivo. Am. J. Pathol. 158,
855–866.
Luttichau, H.R., Stine, J., Boesen,
T. P., Johnsen, A. H., Chantry,
D., Gerstoft, J., and Schwartz, T.
W. (2000). A highly selective CC
chemokine receptor (CCR)8 antago-
nist encodedby the poxvirusmollus-
cum contagiosum. J. Exp. Med. 191,
171–180.
Martin, A., Gallino, N., Gagliardi, J.,
Ortiz, S., Lascano, A. R., Diller, A.,
Daraio, M. C., Kahn, A., Mariani, A.
L., and Serra, H. M. (2002). Early
inﬂammatory markers in elicitation
of allergic contact dermatitis. BMC
Dermatol. 2, 9. doi: 10.1186/1471-
5945-2-9
Meller, S., Lauerma, A. I., Kopp, F. M.,
Winterberg, F., Anthoni, M., Müller,
A., Gombert, M., Haahtela, A., Ale-
nius,H., Rieker, J., Dieu-Nosjean,M.
C., Kubitza, R. C., Gleichmann, E.,
Ruzicka, T., Zlotnik, A., and Homey,
B. (2007). Chemokine responses dis-
tinguish chemical-induced allergic
from irritant skin inﬂammation:
memory T cells make the differ-
ence. J. Allergy Clin. Immunol. 119,
1470–1480.
Meller, S., Winterberg, F., Gilliet,
M., Müller, A., Lauceviciute, I.,
Rieker, J., Neumann, N. J., Kubitza,
R., Gombert, M., Bünemann, E.,
Wiesner, U., Franken-Kunkel, P.,
Kanzler, H., Dieu-Nosjean, M. C.,
Amara, A., Ruzicka, T., Lehmann, P.,
Zlotnik, A., and Homey, B. (2005).
Ultraviolet radiation-induced
injury, chemokines, and leukocyte
recruitment: an ampliﬁcation cycle
triggering cutaneous lupus ery-
thematosus. Arthritis Rheum. 52,
1504–1516.
Meuter, S., and Moser, B. (2008). Con-
stitutive expression of CXCL14 in
healthy human and murine epithe-
lial tissues. Cytokine 44, 248–255.
Meuter, S., Schaerli, P., Roos,R. S., Bran-
dau, O., Bösl, M. R., von Andrian,
U. H., and Moser, B. (2007). Murine
CXCL14 is dispensable for dendritic
cell function and localization within
peripheral tissues. Mol. Cell. Biol. 27,
983–992.
Mikhak, Z., Fukui, M., Farsidjani, A.,
Medoff, B. D., Tager, A. M., and Lus-
ter, A. D. (2009). Contribution of
CCR4 and CCR8 to antigen-speciﬁc
T(H)2 cell trafﬁcking in allergic
pulmonary inﬂammation. J. Allergy
Clin. Immunol. 123, 67–73 e3.
Miller, M. D., and Krangel, M. S.
(1992). The human cytokine I-
309 is a monocyte chemoattrac-
tant. Proc. Natl. Acad. Sci. U.S.A. 89,
2950–2954.
Miller, M. D., Hata, S., De Waal Male-
fyt, R., and Krangel, M. S. (1989).
A novel polypeptide secreted by
activated human T lymphocytes. J.
Immunol. 143, 2907–2916.
Molenaar, R., and Greuter, M., van der
Marel, A. P., Roozendaal, R., Mar-
tin, S. F., Edele, F., Huehn, J., Förster,
R., O’Toole, T., Jansen, W., Eester-
mans, I. L., Kraal, G., and Mebius, R.
E. (2009). Lymph node stromal cells
support dendritic cell-induced gut-
homing of T cells. J. immunol. 183,
6395–6402.
Montes-Vizuet, R., Vega-Miranda, A.,
Valencia-Maqueda, E., Negrete-
García, M. C., Velásquez, J. R., and
Teran, L. M. (2006). CC chemokine
ligand 1 is released into the airways
of atopic asthmatics. Eur. Res. J. 28,
59–67.
Mora, J. R., and Iwata, M., and von
Andrian, U. H. (2008). Vitamin
effects on the immune system: vita-
mins A and D take centre stage. Nat.
Rev. Immunol. 8, 685–698.
Mora, J. R., Cheng, G., Picarella, D.,
Briskin, M., Buchanan, N., and von
Andrian, U. H. (2005). Reciprocal
and dynamic control of CD8 T cell
homing by dendritic cells from skin-
and gut-associated lymphoid tissues.
J. Exp. Med. 201, 303–316.
Morales, J., Homey, B., Vicari, A. P.,
Hudak, S., Oldham, E., Hedrick, J.,
Orozco, R., Copel, N. G., Jenkins,
N. A., McEvoy, L. M., and Zlot-
nik, A. (1999). CTACK, a skin-
associated chemokine that preferen-
tially attracts skin-homing memory
T cells. Proc. Natl. Acad. Sci. U.S.A.
96, 14470–14475.
Morgan, A. J., Guillen, C., Symon, F. A.,
Huynh, T. T., Berry, M. A., Entwisle,
J. J., Briskin, M., Pavord, I. D., and
Wardlaw, A. J. (2005). Expression of
CXCR6 and its ligandCXCL16 in the
lung in health and disease. Clin. Exp.
Allergy 35, 1572–1580.
Morteau, O., Gerard, C., Lu, B., Ghi-
ran, S., Rits, M., Fujiwara, Y., Law,
Y., Distelhorst, K., Nielsen, E. M.,
Hill, E. D., Kwan, R., Lazarus,
N. H., Butcher, E. C., and Wil-
son, E. (2008). An indispensable
role for the chemokine receptor
CCR10 in IgA antibody-secreting
cell accumulation. J. Immunol. 181,
6309–6315.
Mullegger, R. R., Means, T. K., Shin, J.
J., Lee, M., Jones, K. L., Glickstein,
L. J., Luster, A. D., and Steere, A. C.
(2007). Chemokine signatures in the
skin disorders of Lyme borreliosis
in Europe: predominance of CXCL9
and CXCL10 in erythema migrans
and acrodermatitis and CXCL13 in
lymphocytoma. Infect. Immun. 75,
4621–4628.
Mutalithas, K., Guillen, C., Raport, C.,
Kolbeck, R., Soler, D., Brightling,
C. E., Pavord, I. D., and Wardlaw,
A. J. (2010). Expression of CCR8
is increased in asthma. Clin. Exp.
Allergy 40, 1175–1185.
Nakajima, T., Inagaki, N., Tanaka, H.,
Tanaka, A., Yoshikawa, M., Tamari,
M., Hasegawa, K., Matsumoto, K.,
Tachimoto, H., Ebisawa, M., Tsu-
jimoto, G., Matsuda, H., Nagai,
H., and Saito, H. (2002). Marked
increase in CC chemokine gene
expression in both human and
mouse mast cell transcriptomes fol-
lowing Fcepsilon receptor I cross-
linking: an interspecies comparison.
Blood 100, 3861–3868.
Nakayama, T., Fujisawa, R., Yamada,
H., Horikawa, T., Kawasaki, H.,
Hieshima, K., Izawa, D., Fujiie,
S., Tezuka, T., and Yoshie, O.
(2001). Inducible expression
of a CC chemokine liver- and
activation-regulated chemokine
(LARC)/macrophage inﬂammatory
protein (MIP)-3 alpha/CCL20 by
epidermal keratinocytes and its role
in atopic dermatitis. Int. Immunol.
13, 95–103.
Nakayama, T., Watanabe, Y., Oiso, N.,
Higuchi, T., Shigeta, A., Mizuguchi,
N., Katou, F., Hashimoto, K.,
Kawada, A., and Yoshie, O. (2010).
Eotaxin-3/CC chemokine lig-
and 26 is a functional ligand
for CX3CR1. J. Immunol. 185,
6472–6479.
Napolitano, M., Zingoni, A., Bernar-
dini, G., Spinetti, G., Nista, A.,
Storlazzi, C. T., Rocchi, M., and
Santoni, A. (1996). Molecular
cloning of TER1, a chemokine
receptor-like gene expressed by
lymphoid tissues. J. Immunol. 157,
2759–2763.
Narducci, M.G., Scala, E., Bresin, A.,
Caprini, E., Picchio, M. C., Remotti,
D., Ragone, G., Nasorri, F., Frontani,
M.,Arcelli,D.,Volinia, S., Lombardo,
G.A., Baliva,G.,Napolitano,M., and
Russo, G. (2006). Skin homing of
Sezary cells involves SDF-1-CXCR4
signaling and down-regulation of
CD26/dipeptidylpeptidase IV. Blood
107, 1108–1115.
Niederreither, K., and Dolle, P. (2008).
Retinoic acid in development:
towards an integrated view. Nat.
Rev. Genet. 9, 541–553.
Niyonsaba, F., Ushio, H., Nakano, N.,
Ng, W., Sayama, K., Hashimoto,
K., Nagaoka, I., Okumura, K., and
Ogawa, H. (2007). Antimicrobial
peptides human beta-defensins
stimulate epidermal keratinocyte
migration, proliferation and
production of proinﬂammatory
cytokines and chemokines. J. Invest.
Dermatol. 127, 594–604.
Nouri-Aria, K. T., Wilson, D., Francis,
J. N., Jopling, L. A., Jacobson, M.
R., Hodge, M. R., Andrew, D. P.,
Till, S. J., Varga, E. M., Williams,
T. J., Pease, J. E., Lloyd, C. M.,
Sabroe, I., and Durham, S. R. (2002).
CCR4 in human allergen-induced
late responses in the skin and lung.
Eur. J. Immunol. 32, 1933–1938.
Oh, S.T., Schramme, A., Tilgen, W.,
Gutwein, P., and Reichrath, J.
(2009). Overexpression of CXCL16
in lesional psoriatic skin. Derma-
toendocrinol. 1, 114–118.
Olaru, F., and Jensen, L. E. (2010).
Chemokine expression by human
keratinocyte cell lines after activa-
tion of Toll-like receptors. Exp. Der-
matol. 19, e314–316.
Oo, Y. H., Weston, C. J., Lalor, P.
F., Curbishley, S. M., Withers, D.
R., Reynolds, G. M., Shetty, S.,
Harki, J., Shaw, J. C., Eksteen, B.,
Hubscher, S. G., Walker, L. S.,
and Adams, D. H. (2010). Dis-
tinct roles for CCR4 and CXCR3 in
the recruitment and positioning of
regulatory T cells in the inﬂamed
human liver. J. Immunol. 184,
2886–2898.
www.frontiersin.org August 2011 | Volume 2 | Article 33 | 13
McCully and Moser Immune cell homing to the skin
Ottaviani, C., Nasorri, F., Bedini, C.,
de Pità, O., Girolomoni, G., Cavani
A. (2006). CD56brightCD16(-)
NK cells accumulate in psori-
atic skin in response to CXCL10
and CCL5 and exacerbate skin
inﬂammation. Eur. J. Immunol. 36,
118–128.
Pablos, J. L., Mara, A., Bouloc, A.,
Santiago, B., Caruz, A., Galindo,
M., Delaunay, T., Virelizier, J. L.,
and Arenzana-Seisdedos, F. (1999).
Stromal-cell derived factor is
expressed by dendritic cells and
endothelium in human skin. Am. J.
Pathol. 155, 1577–1586.
Pan, J., Kunkel, E. J., Gosslar, U.,
Lazarus, N., Langdon, P., Broadwell,
K., Vierra, M. A., Genovese, M. C.,
Butcher,E. C., and Soler,D. (2000).A
novel chemokine ligand for CCR10
and CCR3 expressed by epithelial
cells in mucosal tissues. J. Immunol.
165, 2943–2949.
Panina-Bordignon, P., Papi, A., Mari-
ani, M., Di Lucia, P., Casoni, G.,
Bellettato, C., Buonsanti, C., Miotto,
D., Mapp, C., Villa, A., Arrigoni,
G., Fabbri, L. M., and Sinigaglia, F.
(2001). The C-C chemokine recep-
tors CCR4 and CCR8 identify air-
way T cells of allergen-challenged
atopic asthmatics. J. Clin. Invest. 107,
1357–1364.
Papadopoulos, E. J., Sassetti, C., Saeki,
H., Yamada, N., Kawamura, T.,
Fitzhugh, D. J., Saraf, M. A., Schall,
T., Blauvelt, A., Rosen, S. D., and
Hwang, S. T. (1999). Fractalkine, a
CX3C chemokine, is expressed by
dendritic cells and is up-regulated
upon dendritic cell maturation. Eur.
J. Immunol. 29, 2551–2559.
Pivarcsi, A., Müller, A., Hippe, A.,
Rieker, J., van Lierop, A., Steinhoff,
M., Seeliger, S., Kubitza, R., Pip-
pirs, U., Meller, S., Gerber, P. A.,
Liersch, R., Buenemann, E., Sonkoly,
E., Wiesner, U., Hoffmann, T. K.,
Schneider, L., Piekorz, R., Ender-
lein, E., Reifenberger, J., Rohr, U.
P., Haas, R., Boukamp, P., Haase,
I., Nürnberg, B., Ruzicka, T., Zlot-
nik, A., and Homey, B. (2007).
Tumor immune escape by the loss
of homeostatic chemokine expres-
sion.Proc.Natl.Acad. Sci.U.S.A. 104,
19055–19060.
Qu, C., Edwards, E. W., Tacke, F., Angeli,
V., Llodrá, J., Sanchez-Schmitz, G.,
Garin, A., Haque, N. S., Peters, W.,
van Rooijen, N., Sanchez-Torres, C.,
Bromberg, J., Charo, I. F., Jung, S.,
Lira, S. A., and Randolph, G. J.
(2004). Role of CCR8 and other
chemokine pathways in the migra-
tion of monocyte-derived dendritic
cells to lymph nodes. J. Exp. Med.
200, 1231–1241.
Raychaudhuri, S. P., Jiang, W. Y., and
Farber, E. M. (2001). Cellular
localization of fractalkine at sites of
inﬂammation: antigen-presenting
cells in Psoriasis express high levels
of fractalkine. Br. J. Dermatol. 144,
1105–1113.
Reichrath, J. (2007). Vitamin D and
the skin: an ancient friend, revisited.
Exp. Dermatol. 16, 618–625.
Reinhardt, R. L., Khoruts, A., Merica,
R., Zell, T., Jenkins, M. K. (2001).
Visualizing the generation of mem-
ory CD4 T cells in the whole body.
Nature 410, 101–105.
Reiss, Y., and Proudfoot, A. E., Power,
C. A., Campbell, J. J., Butcher, E.
C. (2001). CC chemokine receptor
(CCR)4 and the CCR10 ligand cuta-
neous T cell-attracting chemokine
(CTACK) in lymphocyte trafﬁcking
to inﬂamed skin. J. Exp. Med. 194,
1541–1547.
Rimoldi, M., Chieppa, M., Salucci,
V., Avogadri, F., Sonzogni, A.,
Sampietro, G. M., Nespoli, A.,
Viale, G., Allavena, P., and Rescigno,
M. (2005). Intestinal immune
homeostasis is regulated by the
crosstalk between epithelial cells
and dendritic cells. Nat. Immunol. 6,
507–514.
Roos, R.S., Loetscher, M., Legler, D. F.,
Clark-Lewis, I., Baggiolini, M., and
Moser, B. (1997). Identiﬁcation of
CCR8, the receptor for the human
CC chemokine I-309. J. Biol. Chem.
272, 17251–17254.
Roos, T. C., Jugert, F. K., Merk, H. F.,
and Bickers, D. R. (1998). Retinoid
metabolism in the skin. Pharmacol.
Rev. 50, 315–333.
Rottman, J. B., Smith, T. L., Ganley,
K. G., Kikuchi, T., and Krueger,
J. G. (2001). Potential role of
the chemokine receptors CXCR3,
CCR4, and the integrin alphaE-
beta7 in the pathogenesis of Pso-
riasis vulgaris. Lab. Invest. 81,
335–347.
Sallusto, F., Kremmer, E., Palermo,
B., Hoy, A., Ponath, P., Qin,
S., Förster, R., Lipp, M., and
Lanzavecchia, A. (1999). Switch
in chemokine receptor expression
upon TCR stimulation reveals novel
homing potential for recently acti-
vated T cells. Eur. J. Immunol. 29,
2037–2045.
Samson, M., Stordeur, P., Labbé,
O., Soularue, P., Vassart, G., and
Parmentier, M. (1996). Molecular
cloning and chromosomal map-
ping of a novel human gene,
ChemR1, expressed in T lympho-
cytes and polymorphonuclear cells
and encoding a putative chemokine
receptor. Eur. J. Immunol. 26,
3021–3028.
Schaerli, P., Ebert, L., Willimann, K.,
Blaser, A., Roos, R. S., Loetscher,
P., and Moser, B. (2004). A skin-
selective homing mechanism for
human immune surveillance T cells.
J. Exp. Med. 199, 1265–1275.
Schaerli, P., Willimann, K., Ebert, L. M.,
Walz,A., andMoser,B. (2005). Cuta-
neous CXCL14 targets blood precur-
sors to epidermal niches for Langer-
hans cell differentiation. Immunity
23, 331–342.
Schmuth, M., Neyer, S., Rainer, C.,
Grassegger, A., Fritsch, P., Romani,
N., and Heuﬂer, C. (2002). Expres-
sion of the C-C chemokine MIP-
3 alpha/CCL20 in human epider-
mis with impaired permeability bar-
rier function. Exp. Dermatol. 11,
135–142.
Scholz, F., Schulte, A., Adamski, F.,
Hundhausen, C.,Mittag, J., Schwarz,
A., Kruse, M. L., Proksch, E.,
and Ludwig, A. (2007). Constitu-
tive expression and regulated release
of the transmembrane chemokine
CXCL16 in human and murine
skin. J. Invest. Dermatol. 127,
1444–1455.
Sebastiani, S., Albanesi, C., Nasorri,
F., Girolomoni, G., and Cavani, A.
(2002). Nickel-speciﬁc CD4(+) and
CD8(+) T cells display distinct
migratory responses to chemokines
produced during allergic contact
dermatitis. J. Invest. Dermatol. 118,
1052–1058.
Sebastiani, S., Allavena, P., Albanesi,
C., Nasorri, F., Bianchi, G., Traidl,
C., Sozzani, S., Girolomoni, G.,
and Cavani, A. (2001). Chemokine
receptor expression and function
in CD4+ T lymphocytes with reg-
ulatory activity. J. Immunol. 166,
996–1002.
Sells, R. E., and Hwang, S. T. (2010).
Paradoxical increase in skin inﬂam-
mation in the absence of CCR4. J.
Invest. Dermatol. 130, 2697–2699.
Selvan, R. S., Butterﬁeld, J. H., and
Krangel, M. S. (1994). Expression
of multiple chemokine genes by a
human mast cell leukemia. J. Biol.
Chem. 269, 13893–13898.
Selvan, R.S., Zhou, L. J., and Krangel,
M. S. (1997). Regulation of I-309
gene expression in human mono-
cytes by endogenous interleukin-1.
Eur. J. Immunol. 27, 687–694.
Shellenberger, T. D., Wang, M., Gujrati,
M., Jayakumar, A., Strieter, R.
M., Burdick, M. D., Ioannides,
C. G., Efferson, C. L., El-Naggar,
A. K., Roberts, D., Clayman, G.
L., and Frederick, M. J. (2004).
BRAK/CXCL14 is a potent inhibitor
of angiogenesis and a chemotactic
factor for immature dendritic cells.
Cancer Res. 64, 8262–8270.
Shurin, G.V., Ferris, R. L., Tourkova,
I. L., Perez, L., Lokshin, A., Balkir,
L., Collins, B., Chatta, G. S., and
Shurin, M. R. (2005). Loss of new
chemokine CXCL14 in tumor tissue
is associated with low inﬁltration by
dendritic cells (DC), while restora-
tion of human CXCL14 expression
in tumor cells causes attraction of
DC both in vitro and in vivo. J.
Immunol. 174, 5490–5498.
Sigmundsdottir, H., and Butcher, E. C.
(2008). Environmental cues, den-
dritic cells and the programming of
tissue-selective lymphocyte trafﬁck-
ing. Nat. Immunol. 9, 981–987.
Sigmundsdottir, H., Pan, J., Debes, G. F.,
Alt, C., Habtezion, A., Soler, D., and
Butcher, E. C. (2007). DCs metab-
olize sunlight-induced vitamin D3
to “program” T cell attraction to the
epidermal chemokine CCL27. Nat.
Immunol. 8, 285–293.
Sokolov, V.O., Krasnikova, T. L.,
Prokoﬁeva, L. V., Kukhtina, N. B.,
and Areﬁeva, T. I. (2009). Expres-
sion of markers of regulatory CD4
CD25 foxp3 cells in atherosclerotic
plaques of human coronary arteries.
Bull. Exp. Biol. Med. 147, 726–729.
Soler, D., Chapman, T. R., Poisson, L.
R., Wang, L., Cote-Sierra, J., Ryan,
M., McDonald, A., Badola, S., Fedyk,
E., Coyle, A. J., Hodge, M. R., and
Kolbeck, R. (2006). CCR8 expres-
sion identiﬁes CD4 memory T cells
enriched for FOXP3+ regulatory
and Th2 effector lymphocytes. J.
Immunol. 177, 6940–6951.
Sozzani, S., Luini, W., Bianchi, G.,
Allavena, P., Wells, T. N., Napoli-
tano, M., Bernardini, G., Vecchi,
A., D’Ambrosio, D., Mazzeo, D.,
Sinigaglia, F., Santoni, A., Maggi,
E., Romagnani, S., and Mantovani,
A. (1998). The viral chemokine
macrophage inﬂammatory protein-
II is a selective Th2 chemoattractant.
Blood 92, 4036–4039.
Spiekstra, S. W., Toebak, M. J., Sampat-
Sardjoepersad, S., van Beek, P. J.,
Boorsma, D. M., Stoof, T. J., von
Blomberg, B. M., Scheper, R. J.,
Bruynzeel, D. P., Rustemeyer, T.,
and Gibbs, S. (2005). Induction
of cytokine (interleukin-1alpha and
tumor necrosis factor-alpha) and
chemokine (CCL20, CCL27, and
CXCL8) alarm signals after allergen
and irritant exposure. Exp. Derma-
tol. 14, 109–116.
Spinetti, G., Bernardini, G., Camarda,
G., Mangoni, A., Santoni, A.,
Capogrossi, M. C., and Napolitano,
M. (2003). The chemokine recep-
tor CCR8 mediates rescue from
dexamethasone-induced apoptosis
via an ERK-dependent pathway. J.
Leukoc. Biol. 73, 201–207.
Frontiers in Immunology | Chemoattractants August 2011 | Volume 2 | Article 33 | 14
McCully and Moser Immune cell homing to the skin
Starnes, T., Rasila, K. K., Robertson,
M. J., Brahmi, Z., Dahl, R., Christo-
pherson, K., and Hromas, R. (2006).
The chemokine CXCL14 (BRAK)
stimulates activated NK cell migra-
tion: implications for the downreg-
ulation of CXCL14 in malignancy.
Exp. Hematol. 34, 1101–1105.
Sugaya, M., Nakamura, K., Mitsui, H.,
Takekoshi, T., Saeki, H., and Tamaki,
K. (2003). Human keratinocytes
express fractalkine/CX3CL1. J. Der-
matol. Sci. 31, 179–187.
Sumiyoshi, K., Nakao, A., Setoguchi, Y.,
Tsuboi,R.,Okumura,K.,andOgawa,
H. (2003). TGF-beta/Smad signal-
ing inhibits IFN-gamma and TNF-
alpha-induced TARC (CCL17) pro-
duction in HaCaT cells. J. Dermatol.
Sci. 31, 53–58.
Tapia, B., Morel, E., Martín-Díaz, M.
A., Díaz, R., Alves-Ferreira, J., Rubio,
P., Padial, A., and Bellón, T. (2007).
Up-regulation of CCL17, CCL22
and CCR4 in drug-induced mac-
ulopapular exanthema. Clin. Exp.
Allergy 37, 704–713.
Tapia, B., Padial, A., Sánchez-Sabaté,
E., Alvarez-Ferreira, J., Morel, E.,
Blanca, M., and Bellón, T. (2004).
Involvement of CCL27-CCR10
interactions in drug-induced cuta-
neous reactions. J. Allergy Clin.
Immunol. 114, 335–340.
Tiffany, H. L., Lautens, L. L., Gao, J. L.,
Pease, J., Locati, M., Combadiere, C.,
Modi, W., Bonner, T. I., and Mur-
phy, P. M. (1997). Identiﬁcation of
CCR8: a human monocyte and thy-
mus receptor for the CC chemokine
I-309. J. Exp. Med. 186, 165–170.
Tohyama, M., Sayama, K., Komat-
suzawa, H., Hanakawa, Y., Shirakata,
Y., Dai, X., Yang, L., Tokumaru,
S., Nagai, H., Hirakawa, S., Sugai,
M., and Hashimoto, K. (2007).
CXCL16 is a novel mediator of
the innate immunity of epider-
mal keratinocytes. Int. Immunol. 19,
1095–1102.
Tohyama, M., Shirakara, Y., Yamasaki,
K., Sayama, K., and Hashimoto,
K. (2001). Differentiated ker-
atinocytes are responsible for
TNF-alpha regulated production of
macrophage inﬂammatory protein
3alpha/CCL20, a potent chemokine
for Langerhans cells. J. Dermatol.
Sci. 27, 130–139.
Toksoy, A., Müller, V., Gillitzer, R.,
and Goebeler, M. (2007). Biphasic
expression of stromal cell-derived
factor-1 during human wound heal-
ing. Br. J. Dermatol. 157, 1148–1154.
Uchida, T., Suto, H., Ra, C., Ogawa, H.,
Kobata, T., and Okumura, K. (2002).
Preferential expression of T(h)2-
type chemokine and its receptor in
atopic dermatitis. Int. Immunol. 14,
1431–1438.
Van Snick, J., Houssiau, F., Proost, P.,
Van Damme, J., and Renauld, J. C.
(1996). I-309/T cell activation gene-
3 chemokine protects murine T cell
lymphomas against dexamethasone-
induced apoptosis. J. Immunol. 157,
2570–2576.
Vermi, W., Bonecchi, R., Facchetti,
F., Bianchi, D., Sozzani, S., Festa,
S., Berenzi, A., Cella, M., and
Colonna, M. (2003). Recruitment
of immature plasmacytoid dendritic
cells (plasmacytoid monocytes) and
myeloid dendritic cells in primary
cutaneous melanomas. J. Pathol.
200, 255–268.
Vestergaard, C., Bang, K., Gesser, B.,
Yoneyama, H., Matsushima, K.,
and Larsen, C. G. (2000). A Th2
chemokine, TARC, produced by ker-
atinocytes may recruit CLA CCR4
lymphocytes into lesional atopic
dermatitis skin. J. Invest. Dermatol.
115, 640–646.
Vijayanand, P., Durkin, K., Hartmann,
G., Morjaria, J., Seumois, G., Sta-
ples, K. J., Hall, D., Bessant, C.,
Bartholomew, M., Howarth, P. H.,
Friedmann, P. S., and Djukanovic, R.
(2010). Chemokine receptor 4 plays
a key role in T cell recruitment into
the airways of asthmatic patients. J.
Immunol. 184, 4568–4574.
Wakim, L. M., Waithman, J., van Rooi-
jen, N., Heath, W. R., and Carbone,
F. R. (2008). Dendritic cell-induced
memoryT cell activation in nonlym-
phoid tissues. Science 319, 198–202.
Wenzel, J., Henze, S., Wörenkämper, E.,
Basner-Tschakarjan,E., Sokolowska-
Wojdylo, M., Steitz, J., Bieber, T.,
and Tüting, T. (2005). Role of
the chemokine receptor CCR4 and
its ligand thymus- and activation-
regulated chemokine/CCL17 for
lymphocyte recruitment in cuta-
neous lupus erythematosus. J. Invest.
Dermatol. 124, 1241–1248.
Wick, N., Haluza, D., Gurnhofer, E.,
Raab, I., Kasimir, M. T., Prinz,
M., Steiner, C. W., Reinisch, C.,
Howorka, A., Giovanoli, P., Buchs-
baum, S., Krieger, S., Tschachler,
E., Petzelbauer, P., and Kerjaschki,
D. (2008). Lymphatic precollectors
contain a novel, specialized subpop-
ulation of podoplanin low, CCL27-
expressing lymphatic endothelial
cells. Am. J. Pathol. 173, 1202–1209.
Woodland, D. L., and Kohlmeier, J. E.
(2009). Migration,maintenance and
recall of memory T cells in periph-
eral tissues. Nat. Rev. Immunol. 9,
153–161.
Yamanaka, K., Dimitroff, C. J.,
Fuhlbrigge, R. C., Kakeda, M.,
Kurokawa, I., Mizutani, H., and
Kupper, T. S. (2008). Vitamins A
and D are potent inhibitors of
cutaneous lymphocyte-associated
antigen expression. J. Allergy Clin.
Immunol. 121, 148–157 e3.
Yao, L., Salvucci, O., Cardones, A.
R., Hwang, S. T., Aoki, Y., De La
Luz Sierra, M., Sajewicz, A., Pit-
taluga, S., Yarchoan, R., and Tosato,
G. (2003). Selective expression of
stromal-derived factor-1 in the cap-
illary vascular endothelium plays a
role inKaposi sarcomapathogenesis.
Blood 102, 3900–3905.
Ying, S., O’Connor, B., Ratoff, J., Meng,
Q., Fang, C., Cousins, D., Zhang,
G., Gu, S., Gao, Z., Shamji, B.,
Edwards, M. J., Lee, T. H., and Cor-
rigan, C. J. (2008). Expression and
cellular provenance of thymic stro-
mal lymphopoietin and chemokines
in patients with severe asthma and
chronic obstructive pulmonary dis-
ease. J. Immunol. 181, 2790–2798.
Yoshie, O., Fujisawa, R., Nakayama,
T., Harasawa, H., Tago, H., Izawa,
D., Hieshima, K., Tatsumi, Y., Mat-
sushima, K., Hasegawa, H., Kana-
maru, A., Kamihira, S., and Yamada,
Y. (2002). Frequent expression of
CCR4 in adult T-cell leukemia and
human T-cell leukemia virus type
1-transformed T cells. Blood 99,
1505–1511.
Yu, B., Koga, T., Urabe, K., Moroi, Y.,
Maeda, S.,Yanagihara,Y., and Furue,
M. (2002). Differential regulation
of thymus- and activation-regulated
chemokine induced by IL-4, IL-
13, TNF-alpha and IFN-gamma in
human keratinocyte and ﬁbroblast.
J. Dermatol. Sci. 30, 29–36.
Zaballos, A., Varona, R., Gutiérrez, J.,
Lind, P., and Márquez, G. (1996).
Molecular cloning and RNA expres-
sion of two new human chemokine
receptor-like genes. Biochem. Bio-
phys. Res. Commun. 227, 846–853.
Zhang, Y., Luxon, B. A., Casola, A.,
Garofalo, R. P., Jamaluddin, M., and
Brasier, A. R. (2001). Expression of
respiratory syncytial virus-induced
chemokine gene networks in lower
airway epithelial cells revealed by
cDNA microarrays. J. Virol. 75,
9044–9058.
Zheng, X., Nakamura, K., Furukawa,
H., Nishibu, A., Takahashi, M., Tojo,
M., Kaneko, F., Kakinuma, T., and
Tamaki, K. (2003). Demonstration
of TARC and CCR4 mRNA expres-
sion and distribution using in situ
RT-PCR in the lesional skin of
atopic dermatitis. J. Dermatol. 30,
26–32.
Zingoni, A., Soto, H., Hedrick, J.
A., Stoppacciaro, A., Storlazzi, C.
T., Sinigaglia, F., D’Ambrosio, D.,
O’Garra, A., Robinson, D., Roc-
chi, M., Santoni, A., Zlotnik, A.,
and Napolitano, M. (1998). The
chemokine receptor CCR8 is pref-
erentially expressed in Th2 but not
Th1 cells. J. Immunol. 161, 547–551.
Conﬂict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
could be construed as a potential con-
ﬂict of interest.
Received: 17 June 2011; accepted: 26 July
2011; published online: 08 August 2011.
Citation: McCully ML and Moser B
(2011) The human cutaneous chemokine
system. Front. Immun. 2:33. doi:
10.3389/ﬁmmu.2011.00033
This article was submitted to Frontiers in
Chemoattractants, a specialty of Frontiers
in Immunology.
Copyright © 2011 McCully and Moser.
This is an open-access article subject
to a non-exclusive license between the
authors and Frontiers Media SA, which
permits use, distribution and reproduc-
tion in other forums, provided the original
authors and source are credited and other
Frontiers conditions are complied with.
www.frontiersin.org August 2011 | Volume 2 | Article 33 | 15
